0001682220--12-312025Q1falseP1Y0001682220us-gaap:SeriesAPreferredStockMemberus-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001682220us-gaap:SeriesAPreferredStockMember2024-01-012024-03-310001682220us-gaap:CommonStockMember2025-01-012025-03-310001682220us-gaap:SeriesAPreferredStockMembersach:CommonStockThreeMembersach:AtTheMarketOfferingMember2024-10-102024-10-100001682220us-gaap:CommonStockMember2024-01-012024-03-310001682220us-gaap:SeriesAPreferredStockMemberus-gaap:PreferredStockMember2024-01-012024-03-310001682220us-gaap:AdditionalPaidInCapitalMember2025-03-310001682220sach:CumulativeNetEarningsMember2025-03-310001682220sach:CumulativeDividendsPaidMember2025-03-310001682220us-gaap:AdditionalPaidInCapitalMember2024-12-310001682220sach:CumulativeNetEarningsMember2024-12-310001682220sach:CumulativeDividendsPaidMember2024-12-310001682220us-gaap:AdditionalPaidInCapitalMember2024-03-310001682220us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-310001682220sach:CumulativeNetEarningsMember2024-03-310001682220sach:CumulativeDividendsPaidMember2024-03-310001682220us-gaap:AdditionalPaidInCapitalMember2023-12-310001682220us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001682220sach:CumulativeNetEarningsMember2023-12-310001682220sach:CumulativeDividendsPaidMember2023-12-310001682220us-gaap:AdditionalPaidInCapitalMember2025-01-012025-03-310001682220us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-310001682220us-gaap:PreferredStockMember2025-03-310001682220us-gaap:CommonStockMember2025-03-310001682220us-gaap:PreferredStockMember2024-12-310001682220us-gaap:CommonStockMember2024-12-310001682220us-gaap:PreferredStockMember2024-03-310001682220us-gaap:CommonStockMember2024-03-310001682220us-gaap:PreferredStockMember2023-12-310001682220us-gaap:CommonStockMember2023-12-310001682220us-gaap:RestrictedStockMembersach:JohnVillanoMembersach:TwoThousandSixteenEquityPlanMember2025-03-102025-03-100001682220sach:ArthurGoldbergBrianPrinzLeslieBernhardAndJefferyWalravenMemberus-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2025-03-102025-03-100001682220us-gaap:RestrictedStockMembersach:JohnVillanoMembersach:TwoThousandSixteenEquityPlanMember2025-03-252025-03-250001682220us-gaap:RestrictedStockMember2025-01-012025-03-310001682220sach:DaughterOfChiefExecutiveOfficerMember2025-01-012025-03-310001682220sach:DaughterOfChiefExecutiveOfficerMember2024-01-012024-03-310001682220srt:MinimumMemberus-gaap:MortgagesMember2025-01-012025-03-310001682220srt:MaximumMemberus-gaap:MortgagesMember2025-01-012025-03-310001682220us-gaap:ConstructionInProgressMember2025-03-310001682220us-gaap:ConstructionInProgressMember2024-12-310001682220sach:TenantImprovementsMember2024-12-310001682220srt:RetailSiteMember2025-03-310001682220sach:TenantImprovementsMember2025-03-310001682220srt:RetailSiteMember2024-12-310001682220us-gaap:LandMember2025-03-310001682220us-gaap:LandMember2024-12-310001682220us-gaap:SeriesAPreferredStockMember2025-03-310001682220us-gaap:SeriesAPreferredStockMember2024-12-310001682220us-gaap:SeriesAPreferredStockMembersach:CommonStockThreeMembersach:AtTheMarketOfferingMember2022-08-240001682220us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-310001682220sach:CumulativeNetEarningsMember2025-01-012025-03-310001682220sach:CumulativeNetEarningsMember2024-01-012024-03-310001682220us-gaap:MortgagesMember2024-12-310001682220us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001682220us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001682220srt:AffiliatedEntityMember2025-03-310001682220sach:ShareholdersMember2025-03-310001682220srt:AffiliatedEntityMember2024-12-310001682220sach:ShareholdersMember2024-12-310001682220sach:NeedhamCreditFacilityMember2025-01-012025-03-310001682220sach:ChurchillMraFundingILlcRepurchaseFinancingFacilityMember2024-01-012024-12-310001682220srt:SubsidiariesMembersach:NeedhamCreditFacilityMember2025-03-310001682220sach:NeedhamCreditFacilityMember2024-12-310001682220sach:ShemCreekSachemVLlcMember2025-01-012025-03-310001682220sach:ShemCreekSachemViLlcMember2025-01-012025-03-310001682220sach:ShemCreekSachem100LlcMember2025-01-012025-03-310001682220sach:ShemCreekCapitalMember2025-01-012025-03-310001682220sach:ShemCreekCapitalFundVLlcMember2025-01-012025-03-310001682220sach:ShemCreekCapitalFundViLlcMember2025-01-012025-03-310001682220sach:ShemCreekCapitalFundViiLlcMember2025-01-012025-03-310001682220sach:CordoCltInvestorsLlcMember2025-01-012025-03-310001682220sach:CordoCltInvestorsLlcMember2024-09-012024-09-300001682220sach:ShemCreekSachemVLlcMember2024-01-012024-12-310001682220sach:ShemCreekSachemViLlcMember2024-01-012024-12-310001682220sach:ShemCreekSachem100LlcMember2024-01-012024-12-310001682220sach:ShemCreekCapitalMember2024-01-012024-12-310001682220sach:ShemCreekCapitalFundVLlcMember2024-01-012024-12-310001682220sach:ShemCreekCapitalFundViLlcMember2024-01-012024-12-310001682220sach:ShemCreekCapitalFundViiLlcMember2024-01-012024-12-310001682220sach:CordoCltInvestorsLlcMember2024-01-012024-12-310001682220sach:PropertiesHeldForRentalMember2025-01-012025-03-310001682220sach:PropertiesHeldForRentalMember2025-03-310001682220sach:LeasesSpaceToTenantMember2025-03-310001682220us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2025-03-310001682220us-gaap:FairValueInputsLevel1Memberus-gaap:FairValueMeasurementsRecurringMember2024-12-310001682220sach:ShareholdersMember2025-01-012025-03-310001682220sach:ShareholdersMember2024-01-012024-03-310001682220sach:SevenOfShemCreekCapitalLimitedLiabilityCompaniesMember2025-01-012025-03-310001682220sach:SevenOfShemCreekCapitalLimitedLiabilityCompaniesMember2024-01-012024-03-3100016822202025-01-012025-12-310001682220sach:LoansHeldForInvestmentMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2024-12-310001682220sach:LoansHeldForInvestmentMemberus-gaap:FinancingReceivables60To89DaysPastDueMember2024-12-310001682220sach:LoansHeldForInvestmentMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2024-12-310001682220sach:LoansHeldForInvestmentMemberus-gaap:FinancialAssetNotPastDueMember2024-12-310001682220sach:LoansHeldForInvestmentMember2024-12-310001682220sach:LoansHeldForInvestmentMemberus-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember2025-03-310001682220sach:LoansHeldForInvestmentMemberus-gaap:FinancingReceivables60To89DaysPastDueMember2025-03-310001682220sach:LoansHeldForInvestmentMemberus-gaap:FinancingReceivables30To59DaysPastDueMember2025-03-310001682220sach:LoansHeldForInvestmentMemberus-gaap:FinancialAssetNotPastDueMember2025-03-310001682220sach:LoansHeldForInvestmentMember2025-03-310001682220sach:NonaccrualLoansMember2024-01-012024-03-310001682220us-gaap:FinancialAssetNotPastDueMemberus-gaap:ExtendedMaturityMember2025-01-012025-03-310001682220us-gaap:ExtendedMaturityMember2025-01-012025-03-310001682220sach:WestEnglandMember2025-01-012025-03-310001682220sach:FicoScoreUnder500Member2025-03-310001682220sach:FicoScore801To850Member2025-03-310001682220sach:FicoScore751To800Member2025-03-310001682220sach:FicoScore701To750Member2025-03-310001682220sach:FicoScore651To700Member2025-03-310001682220sach:FicoScore601To650Member2025-03-310001682220sach:FicoScore551To600Member2025-03-310001682220sach:FicoScore501To550Member2025-03-310001682220sach:FicoScoreUnder500Member2024-12-310001682220sach:FicoScore801To850Member2024-12-310001682220sach:FicoScore751To800Member2024-12-310001682220sach:FicoScore701To750Member2024-12-310001682220sach:FicoScore651To700Member2024-12-310001682220sach:FicoScore601To650Member2024-12-310001682220sach:FicoScore551To600Member2024-12-310001682220sach:FicoScore501To550Member2024-12-310001682220sach:SouthEnglandMember2025-01-012025-03-310001682220sach:NewEnglandMember2025-01-012025-03-310001682220sach:MidEnglandMember2025-01-012025-03-310001682220srt:SubsidiariesMembersrt:MinimumMembersach:NeedhamCreditFacilityMemberus-gaap:AssetPledgedAsCollateralMember2025-03-200001682220sach:CordoCltInvestorsLlcMember2024-09-300001682220sach:ShemLlcMember2025-03-310001682220sach:ShemCreekSachemVLlcMember2025-03-310001682220sach:ShemCreekSachemViLlcMember2025-03-310001682220sach:ShemCreekSachem100LlcMember2025-03-310001682220sach:ShemCreekCapitalMember2025-03-310001682220sach:ShemCreekCapitalFundVLlcMember2025-03-310001682220sach:ShemCreekCapitalFundViLlcMember2025-03-310001682220sach:ShemCreekCapitalFundViiLlcMember2025-03-310001682220sach:CordoCltInvestorsLlcMember2025-03-310001682220sach:ShemLlcMember2024-12-310001682220sach:ShemCreekSachemVLlcMember2024-12-310001682220sach:ShemCreekSachemViLlcMember2024-12-310001682220sach:ShemCreekSachem100LlcMember2024-12-310001682220sach:ShemCreekCapitalMember2024-12-310001682220sach:ShemCreekCapitalFundVLlcMember2024-12-310001682220sach:ShemCreekCapitalFundViLlcMember2024-12-310001682220sach:ShemCreekCapitalFundViiLlcMember2024-12-310001682220sach:CordoCltInvestorsLlcMember2024-12-310001682220sach:TwoThousandSixteenEquityPlanMember2025-03-310001682220sach:CumulativeDividendsPaidMember2024-01-012024-03-310001682220sach:CumulativeDividendsPaidMember2025-01-012025-03-3100016822202018-04-162018-04-160001682220sach:ChurchillMraFundingILlcRepurchaseFinancingFacilityMember2021-07-210001682220sach:ChurchillMraFundingILlcRepurchaseFinancingFacilityMembersach:RepurchaseAgreementMember2025-03-310001682220sach:ChurchillMraFundingILlcRepurchaseFinancingFacilityMembersach:RepurchaseAgreementMember2024-12-310001682220srt:MaximumMembersach:NeedhamCreditFacilityMember2025-03-310001682220srt:MinimumMembersach:NeedhamCreditFacilityMember2024-12-310001682220sach:ChurchillMraFundingILlcRepurchaseFinancingFacilityMember2024-12-310001682220us-gaap:MortgagesMember2025-03-310001682220sach:UnsecuredUnsubordinatedNotesDueSeptember302027Member2025-03-310001682220sach:UnsecuredUnsubordinatedNotesDueMarch2027Member2025-03-310001682220sach:UnsecuredUnsubordinatedNotesDueJune302027Member2025-03-310001682220sach:UnsecuredUnsubordinatedNotesDueDecember2026Member2025-03-310001682220sach:UnsecuredSubordinatedDebtMember2025-03-310001682220us-gaap:MortgagesMembersach:FederalHomeLoanBankOfBostonClassicAdvanceRateMember2025-01-012025-03-310001682220srt:MinimumMembersach:ChurchillMraFundingILlcRepurchaseFinancingFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMember2021-07-212021-07-210001682220srt:MaximumMembersach:ChurchillMraFundingILlcRepurchaseFinancingFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrMember2021-07-212021-07-210001682220sach:ChurchillMraFundingILlcRepurchaseFinancingFacilityMemberus-gaap:BaseRateMember2021-07-212021-07-210001682220us-gaap:SalesRevenueNetMembersach:MortgageConcentrationRiskMembersach:OneBorrowerMember2025-01-012025-03-310001682220us-gaap:SalesRevenueNetMembersach:MortgageConcentrationRiskMembersach:OneBorrowerMember2024-01-012024-12-3100016822202024-03-3100016822202023-12-310001682220us-gaap:LoansMembersach:MaturityWithingOneYearMember2025-03-310001682220us-gaap:LoansMembersach:MaturityOneYearToTwoYearMember2025-03-310001682220us-gaap:LoansMember2025-03-310001682220us-gaap:LoansMembersach:MaturityWithingOneYearMember2024-12-310001682220us-gaap:LoansMembersach:MaturityOneYearToTwoYearMember2024-12-310001682220us-gaap:LoansMember2024-12-310001682220us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2025-01-012025-03-310001682220sach:SnHoldingsLlcMember2025-03-310001682220sach:TwoThousandSixteenEquityPlanMember2025-01-012025-03-310001682220sach:TwoThousandSixteenEquityPlanMember2024-01-012024-03-310001682220us-gaap:VehiclesMember2025-03-310001682220us-gaap:FurnitureAndFixturesMember2025-03-310001682220us-gaap:ComputerEquipmentMember2025-03-310001682220us-gaap:BuildingMember2025-03-310001682220us-gaap:VehiclesMember2024-12-310001682220us-gaap:FurnitureAndFixturesMember2024-12-310001682220us-gaap:ComputerEquipmentMember2024-12-310001682220us-gaap:BuildingMember2024-12-310001682220srt:MinimumMember2025-01-012025-03-310001682220srt:MaximumMember2025-01-012025-03-310001682220srt:MinimumMember2025-03-310001682220srt:MaximumMember2025-03-310001682220sach:ChurchillMraFundingILlcRepurchaseFinancingFacilityMember2025-01-012025-03-310001682220sach:ArthurGoldbergBrianPrinzAndLeslieBernhardMemberus-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2025-03-102025-03-100001682220us-gaap:RestrictedStockMembersach:TwoThousandSixteenEquityPlanMember2025-03-102025-03-1000016822202023-01-012023-12-3100016822202025-03-102025-03-100001682220us-gaap:RestrictedStockMemberus-gaap:ShareBasedPaymentArrangementNonemployeeMember2025-03-102025-03-100001682220us-gaap:RestrictedStockMembersach:JohnVillanoMember2025-03-102025-03-100001682220us-gaap:RestrictedStockMembersach:TwoThousandSixteenEquityPlanMember2025-01-012025-03-310001682220us-gaap:RestrictedStockMembersach:TwoThousandSixteenEquityPlanMember2024-01-012024-03-310001682220sach:OneBorrowerMember2024-12-310001682220sach:NeedhamCreditFacilityMemberus-gaap:PrimeRateMember2025-01-012025-03-310001682220sach:NeedhamCreditFacilityMemberus-gaap:PrimeRateMember2023-09-082023-09-080001682220us-gaap:UnfundedLoanCommitmentMember2025-03-310001682220sach:LeasesSpaceToTenantMember2025-01-012025-03-3100016822202024-01-012024-12-310001682220sach:OneBorrowerMember2025-03-310001682220sach:UnsecuredUnsubordinatedNotesDueSeptember302025Member2025-03-310001682220sach:ChurchillMraFundingILlcRepurchaseFinancingFacilityMember2021-07-212021-07-210001682220sach:TwoThousandSixteenEquityPlanMember2016-10-270001682220us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2025-03-310001682220us-gaap:FairValueInputsLevel1Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2025-03-310001682220us-gaap:FairValueInputsLevel1Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-12-310001682220us-gaap:FairValueInputsLevel1Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-12-310001682220us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2025-03-310001682220us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2025-03-310001682220us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-12-310001682220us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-12-310001682220sach:NeedhamCreditFacilityMember2025-03-310001682220us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2025-03-310001682220us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsNonrecurringMember2024-12-310001682220us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2025-03-310001682220us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2025-03-310001682220us-gaap:FairValueInputsLevel3Memberus-gaap:EstimateOfFairValueFairValueDisclosureMember2024-12-310001682220us-gaap:FairValueInputsLevel3Memberus-gaap:CarryingReportedAmountFairValueDisclosureMember2024-12-310001682220sach:WestportCtMemberus-gaap:LeasesAcquiredInPlaceMember2025-03-310001682220sach:NonaccrualLoansMember2025-03-310001682220sach:NonaccrualLoansMember2024-12-310001682220sach:WestEnglandMember2025-03-310001682220sach:SouthEnglandMember2025-03-310001682220sach:NewEnglandMember2025-03-310001682220sach:MidEnglandMember2025-03-310001682220sach:WestEnglandMember2024-12-310001682220sach:SouthEnglandMember2024-12-310001682220sach:NewEnglandMember2024-12-310001682220sach:MidEnglandMember2024-12-310001682220sach:NonaccrualLoansMember2025-01-012025-03-310001682220sach:NonaccrualLoansMember2024-01-012024-12-310001682220sach:WestportCtMember2025-03-310001682220sach:ChurchillMraFundingILlcRepurchaseFinancingFacilityMembersach:RepurchaseAgreementMember2025-01-012025-03-310001682220sach:ChurchillMraFundingILlcRepurchaseFinancingFacilityMembersach:RepurchaseAgreementMember2024-01-012024-12-310001682220us-gaap:MortgagesMember2025-01-012025-03-310001682220sach:ChurchillMraFundingILlcRepurchaseFinancingFacilityMember2025-03-3100016822202024-01-012024-03-310001682220sach:AtTheMarketOfferingMember2024-06-172024-06-170001682220sach:CommonStockThreeMember2022-08-242022-08-240001682220srt:MinimumMembersach:NeedhamCreditFacilityMember2025-01-012025-03-310001682220srt:MaximumMembersach:NeedhamCreditFacilityMember2025-01-012025-03-3100016822202025-03-3100016822202024-12-310001682220us-gaap:SeriesAPreferredStockMember2025-01-012025-03-310001682220us-gaap:CommonStockMember2025-01-012025-03-310001682220sach:Notes8.00PercentDue2027Member2025-01-012025-03-310001682220sach:Notes7.75PercentDue2025Member2025-01-012025-03-310001682220sach:Notes7.125PercentDue2027Member2025-01-012025-03-310001682220sach:Notes6.00PercentDue2027Member2025-01-012025-03-310001682220sach:Notes6.00PercentDue2026Member2025-01-012025-03-3100016822202025-05-0100016822202025-01-012025-03-31xbrli:sharesiso4217:USDxbrli:puresach:loaniso4217:USDxbrli:sharessach:borrowersach:propertysach:segment

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2025

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                         to                        

Commission File Number: 001-37997

SACHEM CAPITAL CORP.

(Exact name of registrant as specified in its charter)

New York

    

81-3467779

(State or other jurisdiction of incorporation or organization)

(I.R.S. Employer Identification No.)

568 East Main Street, Branford, CT 06405

(Address of principal executive offices)

(203) 433-4736

(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.         Yes     No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).        Yes         No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer 

Accelerated filer 

Non-accelerated filer 

Smaller reporting company 

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).         Yes         No

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Ticker symbol(s)

    

Name of each exchange on which registered

Common Shares, par value $.001 per share

 

SACH

 

NYSE American LLC

7.75% Notes due 2025

SCCC

NYSE American LLC

6.00% Notes due 2026

SCCD

NYSE American LLC

6.00% Notes due 2027

SCCE

NYSE American LLC

7.125% Notes due 2027

SCCF

NYSE American LLC

8.00% Notes due 2027

SCCG

NYSE American LLC

7.75% Series A Cumulative Redeemable Preferred Stock, Liquidation Preference $25.00 per share

SACHPRA

NYSE American LLC

As of May 1, 2025, the Issuer had a total of 47,310,139 Common Shares, $0.001 par value per share, outstanding.

Table of Contents

SACHEM CAPITAL CORP.

TABLE OF CONTENTS

Part I

FINANCIAL INFORMATION

    

Page Number

Item 1.

Financial Statements

Condensed Consolidated Balance Sheets as of March 31, 2025 (unaudited) and December 31, 2024

1

Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2025 and 2024 (unaudited)

2

Condensed Consolidated Statements of Comprehensive (Loss) Income for the Three Months Ended March 31, 2025 and 2024 (unaudited)

3

Condensed Consolidated Statements of Changes in Shareholders’ Equity for the Three Months Ended March 31, 2025 and 2024 (unaudited)

4

Condensed Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2025 and 2024 (unaudited)

5

Notes to Condensed Consolidated Financial Statements (unaudited)

7

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

24

Item 3.

Quantitative and Qualitative Disclosures about Market Risk

32

Item 4.

Controls and Procedures

32

Part II

OTHER INFORMATION

Item 5.

Other Information

33

Item 6.

Exhibits

34

SIGNATURES

37

EXHIBITS

i

Table of Contents

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q (this “Report”) for the three month period ended March 31, 2025 includes forward-looking statements. All statements other than statements of historical facts contained in this Report, including statements regarding our future results of operations and financial position, strategy and plans, and our expectations for future operations, are forward-looking statements. The words “anticipate,” “estimate,” “expect,” “project,” “plan,” “seek,” “intend,” “believe,” “may,” “might,” “will,” “should,” “could,” “likely,” “continue,” “design,” and the negative of such terms and other words and terms of similar expressions are intended to identify forward-looking statements.

We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, strategy, short-term and long-term business operations and objectives and financial needs. These forward-looking statements are subject to numerous risks, uncertainties and assumptions, some of which are described in our 2024 Annual Report on Form 10-K filed with the U.S. Securities and Exchange Commission (“SEC”). In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this Report may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.

You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, level of activity, performance or achievements. In addition, neither we nor any other person assumes responsibility for the accuracy and completeness of any of these forward-looking statements. We disclaim any duty to update any of these forward-looking statements after the date of this Report to confirm these statements in relationship to actual results or revised expectations.

All forward-looking statements attributable to us are expressly qualified in their entirety by these cautionary statements as well as others made in this Report. You should evaluate all forward-looking statements made by us in the context of these risks and uncertainties.

Unless the context otherwise requires, all references in this Report to “Sachem Capital,” “we,” “us” and “our” refer to Sachem Capital Corp., a New York corporation.

ii

Table of Contents

PART I.        FINANCIAL INFORMATION

Item 1.    FINANCIAL STATEMENTS

SACHEM CAPITAL CORP.

CONDENSED CONSOLIDATED BALANCE SHEETS

(dollars in thousands, except share data)

    

March 31, 2025

    

December 31, 2024

(unaudited)

(audited)

Assets

 

  

 

  

Cash and cash equivalents

$

24,414

$

18,066

Investment securities (at fair value)

1,392

1,517

Loans held for investment (net of deferred loan fees of $2,225 and $1,950)

365,635

375,041

Allowance for credit losses

(18,122)

(18,470)

Loans held for investment, net

347,513

356,571

Loans held for sale (net of valuation allowance of $4,876 and $4,880)

 

10,974

 

10,970

Interest and fees receivable (net of allowance of $2,981 and $3,133)

 

4,281

 

3,768

Due from borrowers (net of allowance of $1,956 and $1,135)

 

4,413

 

5,150

Real estate owned, net

 

18,865

 

18,574

Investments in limited liability companies

53,935

53,942

Investments in developmental real estate, net

 

16,432

 

14,032

Property and equipment, net

3,209

3,222

Other assets

5,967

6,164

Total assets

$

491,395

$

491,976

Liabilities and Shareholders’ Equity

 

  

 

  

Liabilities:

 

  

 

  

Notes payable (net of deferred financing costs of $3,232 and $3,713)

$

227,007

$

226,526

Repurchase agreements

41,519

33,708

Mortgage payable

 

981

 

1,002

Lines of credit

36,100

40,000

Accounts payable and accrued liabilities

2,705

4,377

Advances from borrowers

3,079

4,047

Below market lease intangible

665

665

Total liabilities

312,056

310,325

Commitments and Contingencies - Note 13

 

  

 

  

Shareholders’ equity:

 

  

 

  

Preferred shares - $0.001 par value; 5,000,000 shares authorized; 2,903,000 shares designated as Series A Preferred Stock; 2,306,748 shares of Series A Preferred Stock issued and outstanding at March 31, 2025 and December 31, 2024

2

2

Common Shares - $0.001 par value; 200,000,000 shares authorized; 47,310,139 and 46,965,306 issued and outstanding at March 31, 2025 and December 31, 2024, respectively

 

47

 

47

Additional paid-in capital

 

257,220

 

256,956

Cumulative net earnings

36,422

35,518

Cumulative dividends paid

(114,352)

(110,872)

Total shareholders’ equity

 

179,339

 

181,651

Total liabilities and shareholders’ equity

$

491,395

$

491,976

The accompanying notes, together with the Notes to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, are an integral part of these financial statements.

1

Table of Contents

SACHEM CAPITAL CORP.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited)

(dollars in thousands, except share and per share data)

Three Months Ended

March 31, 

    

2025

    

2024

Revenues

  

 

  

Interest income from loans

$

7,887

$

12,641

Fee income from loans

1,425

2,616

Income from limited liability company investments

2,052

1,195

Other investment income

 

6

 

316

Other income

 

72

 

35

Total revenues

 

11,442

 

16,803

Operating expenses

 

  

 

  

Interest and amortization of deferred financing costs

 

6,094

 

7,469

Compensation and employee benefits

 

1,771

 

1,943

General and administrative expenses

1,355

1,239

Provision for credit losses related to loans held for investment

1,052

1,365

Change in valuation allowance related to loans held for sale

(4)

Loss on sale of real estate owned and property and equipment, net

11

Other expenses

 

145

 

503

Total operating expenses

10,413

12,530

Operating income

 

1,029

4,273

Other (loss) income, net

(Loss) gain on equity securities

(125)

397

Total other (loss) income, net

(125)

397

Net income

904

4,670

Preferred stock dividend

(1,117)

(1,022)

Net (loss) income attributable to common shareholders

$

(213)

$

3,648

Basic and diluted (loss) earnings per Common Share

$

(0.00)

$

0.08

Basic and diluted weighted average Common Shares outstanding

 

46,784,744

 

47,128,511

The accompanying notes, together with the Notes to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, are an integral part of these financial statements.

2

Table of Contents

SACHEM CAPITAL CORP.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME (unaudited)

(dollars in thousands, except share and per share data)

Three Months Ended

March 31, 

    

2025

    

2024

Net income

$

904

 

$

4,670

Other comprehensive income:

Reversal of losses from unrealized to realized

212

Unrealized holding losses on available for sale (“AFS”) securities

(337)

Comprehensive income

$

904

$

4,545

Preferred stock dividend

$

(1,117)

$

(1,022)

Total comprehensive (loss) income attributable to common shareholders

$

(213)

$

3,523

The accompanying notes, together with the Notes to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, are an integral part of these financial statements.

3

Table of Contents

SACHEM CAPITAL CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (unaudited)

(dollars in thousands, except share data)

FOR THE THREE MONTHS ENDED MARCH 31, 2025

Accumulated

Additional 

Other

Preferred Shares

Common Shares

Paid in

Comprehensive

Cumulative

Cumulative

    

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Income (Loss)

    

Net Earnings

Dividends Paid

    

Totals

Balance, January 1, 2025

 

2,306,748

$

2

 

46,965,306

$

47

$

256,956

$

$

35,518

$

(110,872)

$

181,651

Stock-based compensation, less shares forfeited

344,833

264

264

Dividends paid on Series A Preferred Stock

(1,117)

(1,117)

Dividends paid on Common Shares

(2,363)

(2,363)

Net income

 

904

904

Balance, March 31, 2025

2,306,748

$

2

 

47,310,139

$

47

$

257,220

$

$

36,422

$

(114,352)

$

179,339

FOR THE THREE MONTHS ENDED MARCH 31, 2024

Accumulated

Additional

Other

Preferred Shares

Common Shares

Paid in

Comprehensive

Cumulative

Cumulative

    

Shares

    

Amount

    

Shares

    

Amount

    

Capital

    

Income (Loss)

    

Net Earnings

Dividends Paid

    

Totals

Balance, January 1, 2024

 

2,029,923

$

2

 

46,765,483

$

47

$

249,826

$

316

$

75,089

$

(95,204)

$

230,076

Issuance of Series A Preferred Stock, net of expenses

79,034

1,556

1,556

Issuance of Common Shares, net of expenses

568,711

2,049

2,049

Stock-based compensation

111,857

239

239

Reversal of losses from unrealized to realized

212

212

Unrealized holding losses on AFS securities

(337)

(337)

Dividends paid on Series A Preferred Stock

(1,022)

(1,022)

Net income

 

4,670

4,670

Balance, March 31, 2024

2,108,957

$

2

 

47,446,051

$

47

$

253,670

$

191

$

79,759

$

(96,226)

$

237,443

The accompanying notes, together with the Notes to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, are an integral part of these financial statements.

4

Table of Contents

SACHEM CAPITAL CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(dollars in thousands)

Three Months Ended

March 31, 

    

2025

    

2024

CASH FLOWS FROM OPERATING ACTIVITIES

  

 

  

Net income

$

904

$

4,670

Adjustments to reconcile net income to net cash provided by operating activities:

Amortization of deferred financing costs

 

545

 

624

Depreciation expense

 

92

 

94

Stock-based compensation

 

264

 

239

Provision for credit losses related to loans held for investment

 

1,052

 

1,365

Change in valuation allowance related to loans held for sale

(4)

Loss on sale of real estate owned and property and equipment, net

11

Loss (gain) on equity securities

125

(397)

Change in deferred loan fees

275

(291)

Changes in operating assets and liabilities:

 

 

  

Interest and fees receivable, net

 

(361)

 

392

Other assets

 

133

 

(63)

Due from borrowers, net

 

(254)

 

(1,038)

Accounts payable and accrued liabilities

(1,612)

433

Advances from borrowers

 

(968)

 

(1,822)

Total adjustments and operating changes

 

(713)

 

(453)

NET CASH PROVIDED BY OPERATING ACTIVITIES

 

191

 

4,217

CASH FLOWS FROM INVESTING ACTIVITIES

 

  

 

  

Purchase of investment securities

(7,725)

Proceeds from the sale of investment securities

7,128

Purchase of interests in limited liability companies

(4,223)

(3,186)

Proceeds from limited liability companies returns of capital

4,230

Proceeds from sale of real estate owned

89

121

Acquisitions of and improvements to real estate owned

 

 

(749)

Purchase of property and equipment

(41)

(14)

Improvements in investment in developmental real estate

 

(742)

 

Principal disbursements for loans

 

(41,308)

 

(42,654)

Principal collections on loans

 

47,742

 

51,398

NET CASH PROVIDED BY INVESTING ACTIVITIES

 

5,747

 

4,319

CASH FLOWS FROM FINANCING ACTIVITIES

 

  

 

  

Proceeds from lines of credit

 

36,100

 

460

Repayments on lines of credit

 

(40,000)

 

(600)

Proceeds from repurchase agreements

11,693

Repayments of repurchase agreements

 

(3,882)

 

Repayment of mortgage payable

 

(21)

 

(20)

Dividends paid on Common Shares

(2,363)

(5,144)

Dividends paid on Series A Preferred Stock

(1,117)

(1,022)

Proceeds from issuance of Common Shares, net of expenses

2,049

Proceeds from issuance of Series A Preferred Stock, net of expenses

1,556

NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES

 

410

 

(2,721)

NET INCREASE IN CASH AND CASH EQUIVALENTS

 

6,348

 

5,815

CASH AND CASH EQUIVALENTS – BEGINNING OF PERIOD

 

18,066

 

12,598

CASH AND CASH EQUIVALENTS – END OF PERIOD

$

24,414

$

18,413

The accompanying notes, together with the Notes to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, are an integral part of these financial statements.

5

Table of Contents

SACHEM CAPITAL CORP.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (continued) (unaudited)

(dollars in thousands)

Years Ended

March 31, 

    

2025

    

2024

SUPPLEMENTAL DISCLOSURE OF CASH FLOWS INFORMATION

  

 

  

Cash paid during the period for interest

$

5,760

$

6,851

Real estate acquired in connection with foreclosure of certain mortgages

$

410

$

374

Developmental real estate acquired in settlement of loan held for investment

$

1,696

$

Loans originated from sale of real estate owned

$

30

$

The accompanying notes, together with the Notes to the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, are an integral part of these financial statements.

6

Table of Contents

SACHEM CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

1.    The Company

Sachem Capital Corp. (the “Company”), a New York corporation, specializes in originating, underwriting, funding, servicing and managing a portfolio of first mortgage loans. The Company operates its business as one segment. The Company offers short-term (i.e., one to three years), secured, non-bank loans to real estate owners and investors to fund their acquisition, renovation, development, rehabilitation or improvement of properties located primarily in the northeastern and southeastern sections of the United States. The properties securing the Company’s loans are generally classified as residential or commercial real estate and, typically, are held for resale or investment. Each loan is secured by a first mortgage lien on real estate and may also be secured with additional collateral, such as other real estate owned by the borrower or its principals, a pledge of the ownership interests in the borrower by the principals thereof, and/or personal guarantees by the principals of the borrower. The Company’s primary underwriting criteria is a conservative loan to value ratio. In addition, the Company makes opportunistic real estate purchases and investments apart from its lending activities.

2.    Significant Accounting Policies

The significant accounting policies of the Company, unless further updated below, are consistent with those disclosed in Note 2 to the Company’s audited consolidated financial statements for the year ended December 31, 2024 included in the Company’s Annual Report on Form 10-K, filed with the U.S. Securities and Exchange Commission on March 31, 2025.

Unaudited Condensed Consolidated Financial Statements

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by generally accepted accounting principles in the United States of America (“GAAP”) for complete financial statements. However, in the opinion of management, all normal and recurring adjustments considered necessary for a fair presentation have been included. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements for the year ended December 31, 2024 and the notes thereto included in the Company’s Annual Report on Form 10-K. The balance sheet information as of December 31, 2024 is derived from audited financial statements, but does not include all disclosures required by GAAP. Results of operations for the three month period ended March 31, 2025, is not necessarily indicative of the operating results to be attained in the entire fiscal year or for any subsequent period.

Basis of Presentation and Principles of Consolidation

The preparation of the unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases the use of estimates on (a) various assumptions that consider prior reporting results, (b) the Company’s projections regarding future operations and (c) general financial market and local and general economic conditions. Actual amounts could differ from those estimates. Significant estimates include the provisions for current expected credit losses, loans held for sale at fair value and real estate owned.

The accompanying unaudited condensed consolidated financial statements of the Company include the accounts of all subsidiaries in which the Company has control over significant operating, financial and investing decisions of the entity. All intercompany accounts and transactions have been eliminated in consolidation.

Variable Interest Entity

On March 20, 2025, the Company formed SN Holdings LLC (“SN Holdings”), a wholly owned subsidiary of the Company, for the sole purpose of acting as the borrower under a new revolving credit facility with Needham Bank (the “2025 Needham Credit Facility”). Simultaneously with the execution of the new facility, the Company terminated and repaid in full the outstanding balance under its previous facility with Needham Bank.

7

Table of Contents

SACHEM CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

SN Holdings is a variable interest entity (“VIE”) under the guidance of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 810-10, Consolidation, as it was established with insufficient equity at risk and does not have independent operations apart from the parent company. The Company has determined that it is the primary beneficiary of SN Holdings because it has both (i) the power to direct the activities that most significantly impact SN Holdings’ economic performance and (ii) the obligation to absorb losses or the right to receive benefits that could be significant to SN Holdings, primarily through its role as the guarantor of the 2025 Needham Credit Facility and through its ability to direct all operational and financing decisions. Accordingly, SN Holdings has been consolidated in the Company’s financial statements.

As of March 31, 2025, SN Holdings had total assets of $83.5 million and total liabilities of $36.1 million, consisting primarily of collateralized mortgage loans and borrowings under the 2025 Needham Credit Facility. The assets of SN Holdings can only be used to settle obligations of SN Holdings and are not available to the Company or its creditors, other than as permitted under the intercompany guaranty and lien release provisions of the Credit Agreement.

3.    Fair Value Measurement

The following table illustrates assets and liabilities measured at fair value on a recurring basis:

    

Fair Value Measurement

(in thousands)

March 31, 2025

December 31, 2024

Level 1

Investment securities

$

1,392

$

1,517

Level 3

Loans held for sale, net

10,974

10,970

The following table illustrates assets and liabilities measured at fair value on a nonrecurring basis:

    

Fair Value Measurement

(in thousands)

March 31, 2025

December 31, 2024

Level 3

Individually evaluated loans, net of allowance for credit losses

$

83,415

$

80,757

Real estate owned, net

 

18,865

 

18,574

There were no nonrecurring fair value adjustments to the above assets for the three months ended March 31, 2025.

Carrying amounts and fair values of financial instruments at March 31, 2025 and December 31, 2024:

    

Carrying Amount

    

Fair Value Measurement

(in thousands)

    

March 31, 2025

    

December 31, 2024

    

March 31, 2025

    

December 31, 2024

Level 1

Cash and cash equivalents

$

24,414

$

18,066

$

24,414

$

18,066

Notes payable (listed) – fixed rate debt

 

230,239

 

230,239

 

194,802

 

194,810

Investment securities

1,392

1,517

1,392

1,517

Level 2

 

  

 

  

 

  

 

  

Lines of credit and repurchase agreements – variable rate debt

 

77,619

 

73,708

 

77,619

 

73,708

Level 3

 

  

 

  

 

  

 

  

Loans held for investment, net

 

347,513

 

356,571

 

347,513

 

356,571

Loans held for sale, net

 

10,974

 

10,970

 

10,974

 

10,970

Interest and fees receivable and due from borrowers

 

8,694

 

8,918

 

8,694

 

8,918

Investments in limited liability companies

 

53,935

 

53,942

 

53,935

 

53,942

Advances from borrowers

 

3,079

 

4,047

 

3,079

 

4,047

Mortgage payable

 

981

 

1,002

 

981

 

1,002

8

Table of Contents

SACHEM CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

Impact of Fair Value of Available-for-sale Securities on Other Comprehensive Income

The following table presents the impact of the Company’s AFS securities - debt securities on its Other Comprehensive Income (“OCI”) for the three months ended March 31, 2025 and 2024:

Three Months Ended

March 31, 

2025

2024

(in thousands)

OCI from AFS securities – debt securities:

    

  

    

  

Unrealized gain on debt securities at beginning of period

$

$

316

Reversal of losses from unrealized to realized

212

Unrealized holding losses on AFS securities

 

 

(337)

Change in OCI from AFS debt securities

(125)

Balance at end of period

$

$

191

As of March 31, 2025 and December 31, 2024, the Company held no debt securities.

4.    Loans and Allowance for Credit Losses

Loans include loans held for investment that are accounted for at amortized cost net of allowance for credit losses and loans held for sale that are accounted for at the lower of cost or market net of a valuation allowance. The classification for a loan is based on management’s strategy for the loan.

Loans held for investment

As of March 31, 2025 and December 31, 2024, the Company had 143 and 157 loans held for investment, respectively.

As of March 31, 2025 and December 31, 2024, the Company had direct reserves on outstanding principal for loans held for investment of $13.1 million and $13.3 million, respectively.

Loans held for sale

The Company offers mortgage notes receivable to be sold in real estate capital markets. The Company does not originate loans with the intent to designate them as loans held for sale. As of both March 31, 2025 and December 31, 2024, the Company maintained eleven loans held for sale with a gross outstanding principal balance of $15.9 million, of which had an aggregate valuation allowance of $4.9 million in connection with pricing based on lower of cost or market. As of both March 31, 2025 and December 31, 2024, such loans were on nonaccrual status and in pending/pre-foreclosure.

Loan portfolio

As of March 31, 2025 and December 31, 2024, loans held for investment on nonaccrual status had an outstanding principal balance of $107.6 million and $87.0 million, respectively. The nonaccrual loans are inclusive of loans pending foreclosure and loans held for sale. Interest income recorded on nonaccrual loans due to payments received for the three months ended March 31, 2024 was $0.3 million, while such income for the three months ended March 31, 2025 was nominal. The below table summarizes the Company’s loan portfolio by the past due status:

    

Loans held for investment

(in thousands)

    

Current

    

30-59 days past due

    

60-89 days past due

    

Greater than 90 days

    

Total

As of March 31, 2025

$

220,538

$

37,617

$

2,114

$

107,591

$

367,860

As of December 31, 2024

$

223,513

$

49,460

$

16,936

$

87,082

$

376,991

9

Table of Contents

SACHEM CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

As of March 31, 2025, the Company’s mortgage loan portfolio includes loans ranging in size of $0.03 million up to $37.9 million with stated interest rates ranging from 6.5% to 15.0%. The default interest rate is generally 18.0% but could be more or less depending on state usury laws and other considerations deemed relevant by the Company.

As of March 31, 2025 and December 31, 2024, the Company had one borrower representing 13.6% and 14.0% of the outstanding mortgage loan portfolio, or $50.0 million and $55.0 million, respectively.

Deferred loan fees

As of March 31, 2025 and December 31, 2024, the Company had $2.2 million and $2.0 million of deferred loan fee revenue relating to loans held for investment, respectively. There were no such deferred fees for loans held for sale as of March 31, 2025 and December 31, 2024.

Allowance for credit losses

The below table represents the financial statement line items that are impacted by the allowance for credit losses for the three months ended March 31, 2025:

Balance as of

    

Provision for (recovery of) credit

    

    

Balance as of

    

December 31, 2024

    

losses related to loans

    

Charge-offs

    

March 31, 2025

 

(in thousands)

Loans

$

18,470

$

273

$

(621)

$

18,122

Interest and fees receivable

 

3,133

 

(152)

 

 

2,981

Due from borrower

 

1,135

 

991

 

(170)

 

1,956

Unfunded commitments

 

924

 

(60)

 

 

864

Total allowance for credit losses

$

23,662

$

1,052

$

(791)

$

23,923

The following table summarizes the activity in the loans held for investment allowance for credit losses by geographic location for the three months ended March 31, 2025:

Provision for

Allowance for credit losses

Allowance for credit losses as of

(recovery of) credit losses

as of March 31,

    

December 31, 2024

    

related to loans

    

Charge-offs

    

2025

(in thousands)

New England

$

12,844

$

34

$

$

12,878

Mid-Atlantic

 

1,857

 

7

1,864

South

 

1,802

 

279

(621)

1,460

West

 

1,967

 

(47)

1,920

Total

$

18,470

$

273

$

(621)

$

18,122

The following table presents charge-offs by fiscal year of origination for the three months ended March 31, 2025:

    

2025

    

2024

    

2023

    

2022

    

2021

    

Prior

    

Total

(in thousands)

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Current period charge-offs

$

$

134

$

$

487

$

$

$

621

Total

$

$

134

$

$

487

$

$

$

621

10

Table of Contents

SACHEM CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

Presented below is the Company’s loans held for investment portfolio by geographical location:

March 31, 2025

    

December 31, 2024

 

(in thousands)

    

Carrying Value

    

% of Portfolio

    

Carrying Value

    

% of Portfolio

New England

$

175,759

 

47.8

%  

$

179,421

 

47.6

%

Mid-Atlantic

 

42,128

 

11.5

%  

 

42,304

 

11.2

%

South

 

145,872

 

39.7

%  

 

151,165

 

40.1

%

West

 

4,101

 

1.1

%  

 

4,101

 

1.1

%

Total

$

367,860

 

100.0

%  

$

376,991

 

100.0

%

The following tables allocate the carrying value of the Company’s loan portfolio based on credit quality indicators in assessing estimated credit losses and vintage of origination at the dates indicated:

March 31, 2025

Year Originated (1)

Carrying

FICO Score (2)(in thousands)

    

Value

    

2025

    

2024

    

2023

    

2022

    

2021

    

Prior

Loans held for investment:

Under 500

$

140

$

$

140

$

$

$

$

501-550

2,855

1,055

1,800

551-600

4,924

1,222

290

1,816

1,596

601-650

27,774

2,338

7,175

1,663

1,795

7,411

7,392

651-700

35,300

3,938

6,861

11,669

11,502

1,330

701-750

181,430

17,447

5,975

36,480

25,909

92,767

2,852

751-800

109,070

5,604

25,952

31,740

28,535

17,239

801-850

6,367

977

1,146

4,244

Total

$

367,860

$

26,366

$

44,402

$

78,180

$

72,152

$

131,790

$

14,970

December 31, 2024

Year Originated (1)

Carrying

FICO Score (2)(in thousands)

    

Value

    

2024

2023

    

2022

    

2021

    

2020

    

Prior

Loans held for investment:

Under 500

 

$

140

$

140

$

 

$

 

$

 

$

 

$

501-550

 

2,860

 

 

 

1,060

 

 

1,800

551-600

 

7,094

 

1,222

290

 

2,170

 

1,816

 

636

 

960

601-650

 

28,779

 

8,432

3,347

 

1,798

 

7,411

 

6,149

 

1,642

651-700

 

35,711

 

4,250

7,177

 

10,302

 

12,079

 

660

 

1,243

701-750

 

159,575

 

6,275

40,459

 

11,982

 

97,980

 

1,023

 

1,856

751-800

 

124,599

 

26,465

32,016

 

36,280

 

28,427

 

1,411

 

801-850

 

18,233

 

415

 

17,818

 

 

 

Total

$

376,991

$

46,784

$

83,704

 

$

80,350

 

$

148,773

 

$

9,879

 

$

7,501

(1)

Represents the year of origination or amendment where the loan was subject to a full re-underwriting.

(2)

The FICO Scores are calculated at the inception of the loan and are updated if the loan is modified or on an as needed basis.

11

Table of Contents

SACHEM CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

Loan modifications made to borrowers experiencing financial difficulty

The tables below presents loan modifications during the period made to borrowers experiencing financial difficulty:

Three Months Ended March 31, 2025

 

% of Total

 

Carrying Value of

(in thousands)

    

Carrying Value

    

Loans held for investment, net

    

Financial Effect

Term extension

 

$

23,992

 

6.2

%  

A weighted average of 6.7 months were added to the life of the loans

The Company monitors the performance of loans modified during the period to borrowers experiencing financial difficulty. The table below presents the performance of loans that have been modified in the last 12 months to borrowers experiencing financial difficulty. The Company considers loans that are 90 days past due to be in payment default.

Three Months Ended March 31, 2025

(in thousands)

    

Current

    

90-119 days past due

    

120+ days past due

    

Total

Term extension

$

23,922

$

$

$

23,992

The Company has committed to lend additional amounts totaling approximately $0.8 million to borrowers experiencing financial difficulty. Of the loans that were modified that experienced financial difficulties during the three months ended March 31, 2025, no loans defaulted within the three months of the modification. Of the loans that were modified that experienced financial difficulties during the period, one loan with an outstanding principal balance of $0.6 million experienced a rate decrease due to the modification. The change in the rate was taking the loan off default rate.

5. Investment in Developmental Real Estate, net

As of March 31, 2025 and December 31, 2024, investment in developmental real estate, net consisted of the following:

Investment in Rental

March 31, 2025

    

Cost

    

Accumulated Depreciation

    

Real Estate, Net

(in thousands)

Land

$

6,453

$

$

6,453

Building

 

4,936

(185)

4,751

Site improvements

 

359

(36)

323

Tenant improvements

 

1,264

(1)

1,263

Construction in progress

 

3,642

3,642

Total

$

16,654

$

(222)

$

16,432

Investment in Rental

December 31, 2024

    

Cost

    

Accumulated Depreciation

    

Real Estate, Net

(in thousands)

Land

$

4,557

$

$

4,557

Building

 

4,936

(154)

4,782

Site improvements

 

359

(30)

329

Tenant improvements

 

1,223

1,223

Construction in progress

3,141

3,141

Total

$

14,216

$

(184)

$

14,032

12

Table of Contents

SACHEM CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

For the three months ended March 31, 2025 and 2024, depreciation and amortization related to the asset was $0.1 million and $0.1 million, respectively, which is presented in other expenses on the Company’s condensed consolidated statements of operations. Tenant improvements and other intangibles associated with the tenant have begun amortizing in connection with the commencement of the lease that occurred in February 2025. The amounts of amortized costs were nominal for the three months ended March 31, 2025.

Additionally, the Company leases space to a tenant under an operating lease. The lease provides for the payment of fixed base rent payable monthly in advance and periodic step-ups in rent over the term of the lease and a pass through to tenants their share of increases in real estate taxes and operating expenses over a base year. The lease also provides for free rent and a tenant improvement allowance of $2.7 million. The lease commenced February 2025 with a cash rent abatement period of 425 days.

As of March 31, 2025, future minimum rents under non-cancelable operating leases were as follows:

Years Ending December 31,

    

Amount

(in thousands)

2025 (remaining nine months)

$

2026

 

936

2027

 

1,267

2028

 

1,292

2029

 

1,318

Thereafter

 

8,852

Total

$

13,665

As of March 31, 2025, estimated annual amortization of acquired below-market lease intangible is as follows:

Years Ending December 31,

    

Amount

(in thousands)

2025 (remaining nine months)

$

66

2026

 

66

2027

 

66

2028

 

66

2029

 

66

Thereafter

335

Total

$

665

As of March 31, 2025, estimated annual amortization of acquired in-place lease intangible is as follows:

Years Ending December 31,

    

Amount

(in thousands)

2025 (remaining nine months)

$

57

2026

 

57

2027

 

57

2028

 

57

2029

 

57

Thereafter

 

283

Total

$

568

13

Table of Contents

SACHEM CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

As of March 31, 2025, estimated annual amortization of deferred leasing costs is as follows:

Years Ending December 31,

    

Amount

(in thousands)

2025 (remaining nine months)

$

39

2026

 

39

2027

 

39

2028

 

39

2029

 

39

Thereafter

 

192

Total

$

387

6.    Real Estate Owned (“REO”)

Property acquired through foreclosure are included on the condensed consolidated balance sheets as real estate owned and further categorized as held for sale or held for rental, described in detail below.

As of March 31, 2025 and December 31, 2024, real estate owned, net totaled $18.9 million and $18.6 million, respectively. During the three months ended March 31, 2025, the Company’s real estate owned portfolio recorded no impairment loss compared to an impairment loss of $0.5 million for the year ended December 31, 2024, which is considered a Level 3 non-recurring fair market value adjustment.

The following table presents the Company’s REO as of March 31, 2025 (in thousands):

    

March 31, 2025

(in thousands)

Real estate owned at the beginning of period

$

18,574

Principal basis transferred to real estate owned

 

410

Proceeds from sale of real estate owned

 

(119)

Balance at end of period

$

18,865

As of March 31, 2025, REO included $0.8 million of real estate held for rental and $18.1 million of real estate held for sale. As of December 31, 2024, REO included $0.8 million of real estate held for rental and $17.8 million of real estate held for sale.

Properties Held for Sale

During the three months ended March 31, 2025, the Company sold five properties held for sale and recognized a gain on sale that was nominal. During the three months ended March 31, 2024, the Company sold one property held for sale and recognized a gain on sale that was nominal. Such sales are included in, “Loss on sale of real estate owned and property and equipment, net” on the Company’s condensed consolidated Statements of Operations.

Properties Held for Rental

As of March 31, 2025 and December 31, 2024, one property, a commercial building, was held for rental. The tenant signed a 5-year lease that commenced on August 1, 2021.

14

Table of Contents

SACHEM CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

As of March 31, 2025, future minimum rents under this lease were as follows:

Years Ending December 31,

    

Amount

(in thousands)

2025 (remaining nine months)

$

40

2026

 

31

Total

$

71

7.   Property and Equipment, net

The following tables represent the Company’s property and equipment, net as of March 31, 2025 and December 31, 2024:

March 31, 2025

    

Cost

    

Accumulated Depreciation

    

Property and Equipment, Net

 

(in thousands)

Building

$

2,594

$

(127)

$

2,467

Land

 

255

 

 

255

Furniture and fixtures

 

308

 

(133)

 

175

Computer hardware and software

 

298

 

(253)

 

45

Vehicles

 

435

 

(168)

 

267

Total property and equipment, net

$

3,890

$

(681)

$

3,209

December 31, 2024

    

Cost

    

Accumulated Depreciation

    

Property and Equipment, Net

(in thousands)

Building

$

2,557

$

(110)

$

2,447

Land

 

255

 

 

255

Furniture and fixtures

 

308

 

(117)

 

191

Computer hardware and software

 

295

 

(246)

 

49

Vehicles

 

435

 

(155)

 

280

Total property and equipment, net

$

3,850

$

(628)

$

3,222

8.   Other Assets

As of March 31, 2025 and December 31, 2024, other assets consisted of the following:

    

March 31, 2025

    

December 31, 2024

(in thousands)

Prepaid expenses

$

512

$

575

Other receivables

 

1,618

1,793

Other assets

 

30

190

Notes receivable

2,130

2,130

Deferred financing costs, net

201

Deferred leasing cost

387

387

Leases in place intangible

568

568

Goodwill

391

391

Intangible asset – trade name

 

130

130

Total

$

5,967

$

6,164

15

Table of Contents

SACHEM CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

9.    Lines of Credit, Mortgage Payable and Churchill Facility

Line of Credit – Needham Bank

The Company has maintained a Credit and Security Agreement (the “Credit Agreement”) with Needham Bank, a Massachusetts co-operative bank, as the administrative agent (“Needham”) for the lenders party thereto (the “Lenders”) with respect to revolving credit facility (“Needham Credit Facility”) with commitments of $50.0 million and $65.0 million, subject to borrowing base limitations and covenant compliance, at March 31, 2025 and December 31, 2024, respectively.

On March 20, 2025, the Company entered into a new Credit Agreement with Needham Bank, replacing the prior Needham Credit Facility, which was fully repaid and terminated on the same date. The new facility matures on March 2, 2026, and includes an option to extend the term by one year upon satisfaction of certain conditions. Under the new agreement, SN Holdings LLC (“SN Holdings”), a wholly owned subsidiary of the Company, serves as the borrower, and the Company, Sachem Capital Corp., serves as guarantor of all obligations. The Needham Credit Facility is secured by a first priority lien on all the assets of SN Holdings, and includes a requirement that SN Holdings maintain assets equal to at least two times the outstanding principal balance under the facility. In addition, SN Holdings is required to collaterally assign to Needham Bank a portfolio of mortgage loans with an outstanding principal balance of no less than the greater of $30.0 million or the full drawn balance on the facility. The Company, as guarantor, has also granted Needham a blanket lien on substantially all of its assets, with the ability to request lien releases to facilitate other financings. The Needham Credit Facility, at the subsidiary borrower level, is subject to other terms and conditions, including representations and warranties, covenants and agreements typically found in these types of financing arrangements, including a covenant that requires SN Holdings to maintain: (A) a ratio of Adjusted EBITDA (as defined in the Credit Agreement) to Debt Service (as defined in the Credit Agreement) of not less than 1.40 to 1.0, tested on a trailing-twelve-month basis at the end of each fiscal quarter; (B) a sum of cash, cash equivalents (at the consolidated guarantor level) and availability under the facility equal to or greater than $10 million; and (C) an Asset Coverage Ratio (as defined) of at least 150%.

As of March 31, 2025 and December 31, 2024, the total outstanding principal balances on the respective Needham Credit Facilities were $36.1 million and $40.0 million, respectively, with interest rates of 7.25% and 7.25%, respectively.

Loans under the Needham Credit Facility accrue interest at the greater of (i) the annual rate of interest equal to the “prime rate,” as published in the “Money Rates” column of The Wall Street Journal minus one-quarter of one percent (0.25%), and (ii) four and one-half percent (4.50%). Interest is paid monthly. All outstanding revolving loans and accrued but unpaid interest is due and payable on the expiration date. As of March 31, 2025, SN Holdings had $72.9 million of assets pledged to Needham.

The Company was in compliance with all facility covenants as of March 31, 2025.

Mortgage Payable – New Haven Bank

The Company has financed its headquarters property located at 568 East Main Street, Branford, Connecticut with New Haven Bank with an adjustable-rate first lien non-recourse mortgage loan in the original principal amount of $1.7 million (the “NHB Mortgage”). The loan accrues interest at an initial rate of 5.75% per annum for the first 60 months. The interest rate will be adjusted on each of March 1, 2028, and March 1, 2033, to the then published 5-year Federal Home Loan Bank of Boston Classic Advance Rate, plus 1.75%. Beginning on April 1, 2023, and through March 1, 2038, principal and interest will be due and payable on a monthly basis. All payments under the loan are amortized based on a 20-year amortization schedule. Over the next five years, the Company is scheduled to make principal payments ranging from approximately $51,000 to $64,000 annually, with the remaining balance due thereafter. The unpaid principal amount of the loan and all accrued and unpaid interest are due and payable in full on March 1, 2038.

As of March 31, 2025 and December 31, 2024, the total outstanding principal balance on the NHB Mortgage was $1.0 million and $1.0 million, respectively.

16

Table of Contents

SACHEM CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

Churchill MRA Funding I LLC Repurchase Financing Facility

On July 21, 2021, the Company consummated a $200 million master repurchase financing facility (“Churchill Facility”) with Churchill MRA Funding I LLC (“Churchill”), a subsidiary of Churchill Real Estate, a vertically integrated real estate finance company based in New York, New York. Under the terms of the Churchill Facility, the Company has the right, but not the obligation, to sell mortgage loans to Churchill, and Churchill has the right, but not the obligation, to purchase those loans. In addition, the Company has the right and, in some instances the obligation, to repurchase those loans from Churchill. The amount that Churchill will pay for each mortgage loan it purchases will vary based on the attributes of the loan and various other factors. The repurchase price is calculated by applying an interest factor, as defined, to the purchase price of the mortgage loan. The Company has also pledged the mortgage loans sold to Churchill to secure its repurchase obligation. The cost of capital under the Churchill Facility is equal to the sum of (a) the greater of (i) 0.25% and (ii) the 90-day SOFR (which replaced the 90-day LIBOR) plus (b) 3%-4%, depending on the aggregate principal amount of the mortgage loans held by Churchill at that time. As of March 31, 2025 and December 31, 2024, the effective interest rate charged under the facility was 8.31% and 8.69%, respectively.

The Churchill Facility is subject to other terms and conditions, including representations and warranties, covenants and agreements typically found in these types of financing arrangements. Under one such covenant, the Company (A) is prohibited from (i) paying any dividends or making distributions in excess of 90% of its taxable income, (ii) incurring any indebtedness or (iii) purchasing any of its capital stock, unless, it has an asset coverage ratio of at least 150%; and (B) must maintain unencumbered cash and cash equivalents in an amount equal to or greater than 2.50% of the amount of its repurchase obligations. Churchill has the right to terminate the Churchill Facility at any time upon 180 days prior notice to the Company. The Company then has an additional 180 days after termination to repurchase all the mortgage loans held by Churchill.

The Company uses the proceeds from the Churchill Facility to finance the continued expansion of its lending business and for general corporate purposes.

The following table summarizes the outstanding balances under the Churchill Facility agreement:

    

March 31, 2025

    

December 31, 2024

 

Total

Total

 

Outstanding

Rate

 

Outstanding

    

Rate

    

(in thousands)

    

(in thousands)

Repurchase Agreement

$

41,519

 

8.31

%  

$

33,708

 

8.69

%

Total

$

41,519

$

33,708

 

  

The following table summarizes loans held for investment pledged as collateral under the Churchill Facility agreement:

    

March 31, 2025

    

December 31, 2024

Total Carrying Value

Total Carrying Value

Loans Pledged

    

Number of Loans

    

Loans Pledged

    

Number of Loans

    

(in thousands)

(in thousands)

Loans held for investment sold under the repurchase agreement

$

87,746

 

21

$

66,365

 

17

Total

$

87,746

$

66,365

 

  

The following table summarizes the contractual maturities for loans held for investment sold under the repurchase agreement:

    

March 31, 2025

    

December 31, 2024

 

(in thousands)

Maturing within 1 year

 

$

84,670

$

56,050

After 1 but within 2 years

3,076

10,315

Total

 

$

87,746

$

66,365

The NHB Mortgage and the Churchill Facility contain cross-default provisions.

17

Table of Contents

SACHEM CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

10.    Unsecured Notes Payable

At March 31, 2025, the Company had an aggregate of $230.2 million of unsecured, unsubordinated notes payable outstanding, net of $3.2 million of deferred financing costs (collectively, the “Notes”). At March 31, 2025, the Company had five series of Notes outstanding:

(i)Notes having an aggregate principal amount of $56.4 million bearing interest at 7.75% per annum and maturing September 30, 2025 (the “September 2025 Notes”);
(ii)Notes having an aggregate principal amount of $51.8 million bearing interest at 6.0% per annum and maturing December 30, 2026 (the “December 2026 Notes”);
(iii)Notes having an aggregate principal amount of $51.9 million bearing interest at 6.0% per annum and maturing March 30, 2027 (the “March 2027 Notes”);
(iv)Notes having an aggregate principal amount of $30.0 million bearing interest at 7.125% per annum and maturing June 30, 2027 (the “June 2027 Notes”); and
(v)Notes having an aggregate principal amount of $40.3 million bearing interest at 8.00% per annum and maturing September 30, 2027 (the “September 2027 Notes”).

The Notes were sold in underwritten public offerings, were issued in denomination of $25.00 each and are listed on the NYSE American and trade under the symbols “SCCC,” “SCCD,” “SCCE,” “SCCF” and “SCCG,” respectively. All the Notes were issued at par except for the last tranche of the September 2025 notes, in the original principal amount of $28 million, which were issued at $24.75 each. Interest on the Notes is payable quarterly on each March 30, June 30, September 30 and December 30 that they are outstanding. So long as the Notes are outstanding, the Company is prohibited from making distributions in excess of 90% of its taxable income, incurring any additional indebtedness or purchasing any shares of its capital stock unless it has an “Asset Coverage Ratio” of at least 150% after giving effect to the payment of such dividend, the incurrence of such indebtedness or the application of the net proceeds, as the case may be. The Company may redeem the Notes, in whole or in part, without premium or penalty, at any time after their second anniversary of issuance upon at least 30 days prior written notice to the holders of the Notes. The redemption price will be equal to the outstanding principal amount of the Notes redeemed plus the accrued but unpaid interest thereon up to, but not including the date of redemption. Currently, all the Notes are callable at any time.

The following are the future principal payments on the notes payable as of March 31, 2025:

Years ending December 31,

    

Amount

(in thousands)

2025 (remaining nine months)

 

$

56,364

2026

 

51,750

2027

 

122,125

Total principal payments

 

$

230,239

Deferred financing costs

 

(3,232)

Total notes payable, net of deferred financing costs

$

227,007

18

Table of Contents

SACHEM CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

The estimated amortization of the deferred financing costs as of March 31, 2025 is as follows:

Years ending December 31,

    

Amount

(in thousands)

2025 (remaining nine months)

 

$

1,328

2026

 

1,410

2027

 

494

Total deferred costs

$

3,232

11.   Accounts Payable and Accrued Liabilities

As of March 31, 2025 and December 31, 2024, accounts payable and accrued liabilities include the following:

    

March 31, 2025

    

December 31, 2024

(in thousands)

Accounts payable and accrued expenses

 

$

1,544

$

2,928

Allowance for credit losses on unfunded commitments

864

924

Accrued interest

 

297

525

Total

$

2,705

$

4,377

12.   Fee Income from Loans

For the three months ended March 31, 2025 and 2024, fee and other income consisted of the following:

Three Months Ended

March 31, 

    

2025

    

2024

(in thousands)

Origination and modification fees

$

780

$

1,462

Extension fees

278

114

Late and other fees

79

283

Processing fees

 

21

35

Construction servicing fees

137

179

Legal fees

63

82

Other fees

67

461

Total

$

1,425

$

2,616

13.   Commitments and Contingencies

Unfunded Commitments

At March 31, 2025, the Company had future funding obligations on loans held for investment totaling $46.4 million and obligations relating to investments in limited liability companies totaling $4.8 million, which can be drawn by the borrowers when the conditions relating thereto have been satisfied. The unfunded commitments will be funded from loan payoffs and additional drawdowns under existing and future credit facilities and proceeds from sale of debt and equity securities. The Company’s unfunded commitments are subject to allowances under the scope of CECL, see Note 4 – Loans and Allowance for Credit Losses for further details.

19

Table of Contents

SACHEM CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

Litigation

The Company is subject to various pending and threatened legal proceedings or other matters arising out of the normal conduct of business in which claims for monetary damages are asserted. As of the date of this report, management, after consultation with legal counsel, does not anticipate that the aggregate ultimate liability arising out of such pending or threatened matters will be material to the Company’s consolidated financial position. On at least a quarterly basis, the Company assesses its liabilities and contingencies in connection with such matters. For those matters where it is probable that the Company will incur losses and the amounts of the losses can be reasonably estimated, the Company records an expense and corresponding liability in its condensed consolidated financial statements. To the extent such matters could result in exposure in excess of that liability, the amount of such excess is not currently estimable. The range of losses for matters where an exposure is not currently estimable or considered probable is not believed to be material in the aggregate. This is based on information currently available to the Company and involves elements of judgment and significant uncertainties. While the Company does not believe that the outcome of pending or threatened litigation or other matters will be material to the Company’s consolidated financial position, it cannot rule out the possibility that such outcomes will be material to the consolidated results of operations for a particular reporting period in the future. In addition, regardless of the ultimate outcome of any such legal proceeding, inquiry or investigation, any such matter could cause the Company to incur additional expenses, which could be significant, and possibly material, to the Company’s results of operations in any future period.

Other

In the normal course of its business, the Company is named as a party-defendant in connection with tax foreclosure proceedings against properties on which it holds a first mortgage lien. The Company actively monitors these actions and, in all cases, believes there remains sufficient value in the subject property to assure that no loan impairment exists. At March 31, 2025, there were two such properties. The unpaid principal balance on the properties that are subject to these proceedings was $1.9 million.

14.   Related Party Transactions

In the ordinary course of business, the Company may originate, fund, manage and service loans to shareholders. The underwriting process on these loans adheres to prevailing Company policy. The terms of such loans, including the interest rate, income, origination fees, and other closing costs are the same as those applicable to loans made to unrelated third parties in the portfolio. As of March 31, 2025, and December 31, 2024, loans to known shareholders totaled $17.2 million and $17.2 million, respectively, which is included in loans held for investment, net in the Company’s accompanying condensed consolidated balance sheets. Of the $17.2 million and $17.2 million loans to known shareholders as of March 31, 2025 and December 31, 2024, respectively, $16.9 million and $17.0 million, respectively, related to Mod 21, LLC, which is a wholly owned entity of the Company’s Senior Vice President of Asset Management and Vice President of Asset Management. All such loans are performing and interest income earned on all related party loans for the three months ended March 31, 2025 and 2024 totaled $0.3 million and $0.6 million, respectively.

In December 2021, the Company hired the daughter of the Company’s chief executive officer to perform certain internal audit and compliance services. For the three months ended March 31, 2025 and 2024, she received compensation of $43,269 and $37,500, respectively.

15.   Stock-Based Compensation and Employee Benefits

Stock-Based Compensation

On October 27, 2016, the Company adopted the 2016 Equity Compensation Plan (the “Plan”), the purpose of which is to align the interests of the Company’s officers, other employees, advisors and consultants or any subsidiary, if any, with those of the Company’s shareholders and to afford an incentive to such officers, employees, consultants and advisors to continue as such, to increase their efforts on the Company’s behalf and to promote the success of the Company’s business. The Plan is administered by the Compensation Committee. The maximum number of Common Shares reserved for the grant of awards under the Plan is 1,500,000, subject to adjustment as provided in Section 5 of the Plan. The number of securities remaining available for future issuance under the Plan as of March 31, 2025 was 436,762. The number of shares issuable to any one individual in a plan year is also limited to 100,000 shares, subject to adjustment as provided for in the Plan.

20

Table of Contents

SACHEM CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

During the three months ended March 31, 2025 and 2024, the Company granted an aggregate of 767,668 and 111,857, respectively, restricted Common Shares under the Plan. Such shares during the three months ended March 31, 2025 and 2024 had a fair value of $0.9 million and $0.5 million, respectively. Of the 767,668 shares granted, 420,168 shares were forfeited immediately as discussed further below.

On March 10, 2025, the Company’s Compensation Committee authorized (i) a grant of 420,168 restricted Common Shares to John L. Villano, which shares had a fair market value on the date of grant of approximately $0.5 million; and (ii) a one-time bonus grant of 20,000 restricted Common Shares to each of the Company’s non-employee directors, Arthur Goldberg, Brian Prinz, Leslie Bernhard and Jeffery Walraven. Each of the Company’s non-employee directors, with the except for Mr. Walraven, also had the option, at his or her election, to receive the fair market value equivalent of his or her grant in a lump sum cash payment of $23,800. An aggregate of 60,000 restricted Common Shares were granted to the Company’s non-employee directors, which shares had an aggregate fair market value on the date of grant of approximately $71,400. Ms. Bernhard elected to receive the lump sum cash payment.

The Company identified subsequent to the above March 10, 2025 action of the Company’s Compensation Committee regarding authorization of issuance of 420,168 share of restricted stock to John L. Villano under the effective 2016 Equity Compensation Plan that it had over authorized on the total issuance by 320,168 shares. The over issuance is a result of a specified limitation in the Plan that no more than 100,000 shares of restricted Common Shares may be made subject to awards to a single individual in a single plan year, subject to adjustments as provided. No identified adjustment provisions were deemed applicable. In result of this identification it was also determined that in calendar 2023 and 2024 there were additional similar over issuances of 30,890 and 11,857, respectively. In total there were 362,915 restricted shares which have been issued in excess of Plan limitations, all of which still remain unvested and restricted. No other plan years have identified any additional over issuances. In an immediate full and in excess of necessary remediation of this matter on March 25, 2025, John L. Villano voluntarily forfeited the 420,168 shares that were granted on March 10, 2025.

Stock-based compensation for the three months ended March 31, 2025 and 2024 was $0.3 million and $0.2 million, respectively. As of March 31, 2025, there was unrecognized stock-based compensation expense of $0.9 million. Additionally, during the three months ended March 31, 2025, the Company had 2,667 of unvested restricted Common Shares forfeited to the Company as a result of the resignation of a former employee.

Employee Benefits

On April 16, 2018, the Company’s Board of Directors approved the adoption of the Sachem Capital Corp. 401(k) Profit Sharing Plan (the “401(k) Plan”). All employees, who meet the participation criteria, are eligible to participate in the 401(k) Plan. Under the terms of the 401(k) Plan, the Company is obligated to contribute 3% of a participant’s compensation to the 401(k) Plan on behalf of an employee-participant. For the three months ended March 31, 2025 and 2024, the 401(k) Plan expense was $24,293 and $48,210, respectively, which is included within compensation, fees, and taxes in the accompanying condensed consolidated statements of comprehensive income.

16.   Equity

On August 24, 2022, the Company filed a prospectus supplement to its Form S-3 Registration Statement covering the sale of up to $75.0 million of its Common Shares and shares of its Series A Preferred Stock with an aggregate liquidation preference of up to $25.0 million in an “at-the market” offering (the “ATM Offering”). On June 17, 2024, the Company filed a new prospectus supplement (the “New Prospectus Supplement”) which modified the ATM Offering by reducing the amount of Common Shares the Company may offer and sell to up to an aggregate of $48.7 million, including the Common Shares the Company has already sold in the ATM Offering prior to the date of the New Prospectus Supplement. All the other terms of the ATM Offering remained the same. During the three months ended March 31, 2025, the Company did not sell any shares under the ATM Offering. In February 2025, the effectiveness of the S-3 Registration Statement expired and, as a result, the ATM Offering terminated.

21

Table of Contents

SACHEM CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

In October 2022, the Board adopted a stock repurchase plan (the “Original Repurchase Plan”), pursuant to which the Company may repurchase up to an aggregate of $7.5 million of its Common Shares. Under the Original Repurchase Plan, share repurchases were made from time to time on the open market at prevailing market prices or in negotiated transactions off the market in accordance with applicable federal securities laws, including Rule 10b-18 and 10b5-1 of the Exchange Act. The Original Repurchase Plan expired on October 9, 2024.

Effective on October 10, 2024, the Board replaced the Original Repurchase Plan with a new stock repurchase plan (the “New Repurchase Plan”). Under the New Repurchase Plan, the Company may repurchase up to an aggregate of $5,802,959 (the amount remaining under the Original Purchase Plan) of Common Shares and share repurchases will be made from time to time on the open market at prevailing market prices in accordance with applicable federal securities laws, including Rule 10b-18 of the Exchange Act.

During the three months ended March 31, 2025, the Company did not repurchase any Common Shares under the New Repurchase Plan.

17.   Earnings (Losses) Per Share

Basic and diluted earnings (losses) per share are calculated in accordance with FASB ASC 260 (Earnings Per Share). Under FASB ASC 260, basic earnings per share is computed by dividing net income (loss) available to the common shareholders by the weighted-average number of Common Shares outstanding for the period. The computation of diluted earnings (losses) per share is similar to basic earnings (losses) per share, except that the denominator is increased to include the potential dilution from our unvested restricted stock awards that contain non-forfeitable rights to dividends so therefore deemed to participating securities for Common Shares using the treasury stock method. The numerator in calculating both basic and diluted earnings (losses) per common share for each period is the reported net income (loss) available to common shareholders.

For the three months ended March 31, 2025, the Company had basic and diluted weighted average Common Shares of 46,784,744 outstanding, resulting in basic and diluted loss per share of $0.00. For the three months ended March 31, 2024, the Company had basic and diluted weighted average Common Shares of 47,128,511 outstanding, resulting in basic and diluted earnings per share of $0.08.

18.   Limited Liability Company (“LLC”) Investments

The following table details the carrying value of each investment reflected on our condensed consolidated balance sheets as of March 31, 2025:

March 31, 2025

December 31, 2024

 

 

Carrying

 

Carrying

Investment

    

Value

    

Ownership Percentage

    

Value

    

Ownership Percentage

 

(in thousands)

 

(in thousands)

Shem Creek Capital Fund V LLC

$

1,130

 

7.6

%  

$

1,143

 

7.6

%

Shem Creek Capital Fund VI LLC

 

3,897

 

9.9

%  

 

4,290

 

9.9

%

Shem Creek Capital Fund VII LLC

 

2,580

 

16.2

%  

 

2,580

 

16.2

%

Shem Creek Sachem V LLC

 

2,528

 

49.0

%  

 

2,569

 

49.0

%

Shem Creek Sachem VI LLC

 

20,988

 

45.4

%  

 

24,756

 

45.9

%

Shem Creek Sachem 100 LLC

 

15,312

 

100.0

%  

 

13,604

 

100.0

%

Shem Creek Capital LLC

 

5,000

 

20.0

%  

 

2,500

 

20.0

%

Total Shem LLC Invemestments

$

51,435

$

51,442

Cordo CLT Investors LLC

$

2,500

 

7.2

%  

$

2,500

 

7.2

%

Total investments in LLC’s

$

53,935

 

$

53,942

 

  

Shem Creek (“Shem”)

For the three months ended March 31, 2025 and 2024, the Shem LLC investments generated $2.1 million and $1.2 million, respectively, of income for the Company.

22

Table of Contents

SACHEM CAPITAL CORP.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2025

At March 31, 2025, the Company had unfunded commitments totaling $4.8 million in the Shem LLC entities.

Cordo CLT Investors LLC

In September 2024, the Company, through its wholly owned subsidiary Urbane Capital, LLC, initially acquired a 21.6% interest in Cordo CLT Investors LLC for a one time contribution of $2.5 million. As of March 31, 2025 and December 31, 2024, the Company held 7.2% and 7.2%, respectively, of total common member equity. This entity was formed for the sole purpose of developing a commercial multifamily property in Charlotte, North Carolina. The Company anticipates the project to be completed by the end of 2026.

19.   Income Taxes

The Company believes it qualifies as a real estate investment trust (“REIT”) for federal income tax purposes and operates accordingly. It made the election to be taxed as a REIT on its 2017 Federal income tax return. The Company’s qualification as a REIT depends on its ability to meet on a continuing basis, through actual investment and operating results, various complex requirements under the Internal Revenue Code of 1986, as amended (the “Code”), relating to, among other things, the sources of its income, the composition and values of its assets, its compliance with the distribution requirements applicable to REITs, and the diversity of ownership of its outstanding capital stock. So long as it qualifies as a REIT, the Company, generally, will not be subject to U.S. federal income tax on its taxable income distributed to its shareholders. However, if it fails to qualify as a REIT in any taxable year and does not qualify for certain statutory relief provisions, it will be subject to U.S. federal income tax at regular corporate rates and may also be subject to various penalties and may be precluded from re-electing REIT status for the four taxable years following the year during in which it lost its REIT qualification. Other than taxes incurred by the Company’s taxable REIT subsidiary (“TRS”), the Company does not expect to incur any corporate federal income tax liability, as it believes it has maintained its qualification as a REIT.

The Company has elected, and may elect in the future, to treat certain of its existing or newly created corporate subsidiaries as TRSs. In general, a TRS may hold assets that the Company cannot hold directly and generally may engage in any real estate or non-real estate related business. The TRSs generate income, resulting in federal and state income tax liability for these entities. During the three months ended March 31, 2025 and 2024, the Company’s TRSs recognized provisions for federal and state income tax of $0.0 million and $0.2 million, respectively, which is represented in Other expenses on the Company’s condensed consolidated statements of operations.

The income tax provision for the Company differs from the amount computed from applying the statutory federal income tax rate to income before income taxes due to non-taxable REIT income and other permanent differences including the non-deductibility of acquisition costs of business combinations for federal income tax reporting.

FASB ASC Sub-Topic 740-10 “Accounting for Uncertainty in Income Taxes” prescribes a recognition threshold and measurement attribute for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return and disclosure required. Under this standard, an entity may only recognize or continue to recognize tax positions that meet a “more likely than not” threshold. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits in interest expense. The Company has determined that there are no uncertain tax positions requiring accrual or disclosure in the accompanying condensed consolidated financial statements as of March 31, 2025 and December 31, 2024.

20.   Subsequent Events

The Company evaluated subsequent events from April 1, 2025 until the financial statements were available to be issued.

23

Table of Contents

Item 2.   MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion of the Company’s financial condition and results of operations should be read in conjunction with the accompanying unaudited condensed consolidated financial statements and the notes to those statements included elsewhere in this Report. Certain statements in this discussion and elsewhere in this Report constitute forward-looking statements, within the meaning of section 21E of the Exchange Act, that involve risks and uncertainties. Actual operating results and financial conditions may differ materially from those anticipated in these forward-looking statements.

Company Overview

Sachem Capital Corp., a New York corporation, established in 2010 and completing an initial public offering in 2017 is a self-managed REIT that specializes in originating, underwriting, funding, servicing and managing a portfolio of first mortgage loans. We operate our business as one segment. We offer short-term (i.e., one to three years), secured, non-bank loans to real estate owners and investors to fund their acquisition, renovation, development, rehabilitation or improvement of properties located primarily in the northeastern and southeastern sections of the United States. The properties securing our loans are generally classified as residential or commercial real estate and, typically, are held for resale or investment. Each loan is secured by a first mortgage lien on real estate and may also be secured with additional collateral, such as other real estate owned by the borrower or its principals, a pledge of the ownership interests in the borrower by the principals thereof, and/or personal guarantees by the principals of the borrower. Our primary underwriting criteria is a conservative loan to value ratio. In addition, we may make opportunistic real estate purchases and investments apart from our lending activities.

Critical Accounting Policies and Use of Estimates

Preparing our unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. We base the use of estimates on (a) various assumptions that consider prior reporting results, (b) our projections regarding future operations, and (c) general financial market and local and general economic conditions. Actual amounts could differ from those estimates. Significant estimates include the provisions for current expected credit losses, loans held for sale at fair value, and real estate owned. See Note 2 – Significant Accounting Policies for further details.

Revenue Recognition

Interest income from commercial loans is recognized, as earned, over the loan period, whereas origination and modification fee revenue on commercial loans are amortized over the term of the respective notes.

24

Table of Contents

CECL Allowance

We record an allowance for credit losses (“CECL”) in accordance with the CECL standard on our loan portfolio, including unfunded construction commitments, on a collective basis by assets with similar risk characteristics. This methodology replaces the probable incurred loss impairment methodology. In addition, interest and fees receivable and amounts included in due from borrowers, other than reimbursements, which include origination, modification and other fees receivable are also analyzed for credit losses in accordance with the CECL standard, as they represent a financial asset that is subject to credit risk. Further, CECL requires credit losses to be presented as an allowance rather than as a write-down on available-for-sale debt securities if management does not intend to sell and does not believe that it is more likely than not, they will be required to sell. As allowed under the CECL standard that we have adopted, as a practical expedient, the fair value of the collateral at the reporting date is compared to the net carrying amount of the loan when determining the allowance for credit losses for loans in pending/pre-foreclosure status, as defined. Fair value of collateral is reduced by estimated cost to sell if the collateral is expected to be sold. The CECL standard requires an entity to consider historical loss experience, current conditions, and a reasonable and supportable forecast of the economic environment. We utilize a loss-rate method for estimating current expected credit losses. The loss rate method involves applying a loss rate to a pool of loans with similar risk characteristics to estimate the expected credit losses on that pool of loans. In determining the CECL allowance, we consider various factors including (1) historical loss experience in its portfolio, (2) loan specific losses for loans deemed collateral dependent based on excess amortized cost over the fair value of the underlying collateral, and (3) its current and future view of the macroeconomic environment. We also utilize a reasonable and supportable forecast period equal to the contractual term of the loan plus any applicable short-term extensions that are reasonably expected for construction loans. Loans, interest receivable, due from borrowers, unfunded commitments, and (available-for-sale debt) investment securities are all presented net on the Condensed Consolidated Balance Sheets with expanded disclosures in the notes to the condensed consolidated financial statements. The change in the balances during the reporting period are recorded in the Condensed Consolidated Statements of Operations under the provision for credit losses.

Our Loan Portfolio

The following table highlights certain information regarding our real estate lending activities for the three months ended March 31, 2025 (in thousands, except number of loans and weighted averages):

March 31, 2025

(in thousands, except number 

    

of loans and weighted averages)

Loans disbursed

$

41,308

Loans repaid

$

47,742

Principal of loans transferred to real estate owned

$

410

Number of loans transferred to real estate owned

 

1

Number of loans held for investment outstanding

 

143

Gross principal amount of loans held for investment

$

367,860

Weighted average contractual interest rate(1)

 

12.88

%  

Weighted average term to maturity (in months) (2)

 

4

(1)Includes default interest.

(2)Does not give effect to extensions.

25

Table of Contents

At March 31, 2025, our outstanding mortgage loan portfolio included loans ranging in size from $35,000 to $42.8 million. The table below gives a breakdown of our loans held for investment by loan size as of March 31, 2025:

    

    

    

    

Aggregate Gross

    

    

 

Number of

Principal

 

Amount

Loans

Percentage

Amount

Percentage

 

 

(in thousands)

$1,000,000 or less

 

68

 

47.6

%  

$

27,410

 

7.5

%

$1,000,001 to $5,000,000

 

58

 

40.6

%  

 

132,637

 

36.1

%

$5,000,001 to $10,000,000

 

7

 

4.8

%  

 

44,260

 

12.0

%

$10,000,001 or more

 

10

 

7.0

%  

 

163,553

 

44.4

%

Total

 

143

 

100.0

%  

$

367,860

 

100.0

%

As of March 31, 2025, the primary markets in which we were exposed were Connecticut, Florida, Massachusetts and New York. The table below gives a breakdown of our loans held for investment by state as of March 31, 2025:

    

Number of

    

    

Gross Amount

    

    

 

State

Loans

Percentage

Outstanding

Percentage

 

 

(in thousands)

California

 

1

 

0.7

%  

$

4,101

 

1.1

%

Connecticut

 

73

 

51.0

%  

 

119,013

 

32.4

%

Florida

 

19

 

13.3

%  

 

108,742

 

29.6

%

Georgia

 

1

 

0.7

%  

 

3,840

 

1.0

%

Maine

 

1

 

0.7

%  

 

1,625

 

0.4

%

Maryland

 

1

 

0.7

%  

 

864

 

0.2

%

Massachusetts

 

10

 

7.0

%  

 

53,200

 

14.5

%

New Jersey

 

1

 

0.7

%  

 

2,342

 

0.6

%

New York

 

21

 

14.7

%  

 

32,840

 

8.9

%

North Carolina

 

4

 

2.8

%  

 

7,877

 

2.1

%

Pennsylvania

 

2

 

1.4

%  

 

4,856

 

1.3

%

Rhode Island

 

3

 

2.1

%  

 

1,921

 

0.5

%

South Carolina

 

4

 

2.8

%  

 

12,755

 

3.5

%

Tennessee

 

1

 

0.7

%  

 

12,658

 

3.5

%

Washington D.C.

 

1

 

0.7

%  

 

1,226

 

0.4

%

Total

 

143

 

100.0

%  

$

367,860

 

100.0

%

The following table details our loans held for investment as of March 31, 2025 by year of origination:

    

    

    

    

Aggregate Gross

    

    

 

Number of

Principal

 

Year of Origination

Loans

Percentage

Amount

Percentage

 

 

(in thousands)

2025

 

7

 

4.9

%  

$

26,366

 

7.1

%

2024

 

31

 

21.7

%  

 

44,402

 

12.1

%

2023

 

27

 

18.9

%  

 

78,180

 

21.3

%

2022

 

28

 

19.6

%  

 

72,152

 

19.6

%

2021

 

31

 

21.7

%  

 

131,790

 

35.8

%

2020

 

5

 

3.5

%  

 

7,628

 

2.1

%

2019 and prior

 

14

 

9.7

%  

 

7,342

 

2.0

%

Total

 

143

 

100.0

%  

$

367,860

 

100.0

%

26

Table of Contents

The following tables set forth information regarding the types of properties securing loans held for investment as of March 31, 2025 and December 31, 2024:

March 31, 2025

December 31, 2024

 

(in thousands)

 

Aggregate Gross Principal

Aggregate Gross Principal

 

    

Amount

    

Percentage

    

Amount

    

Percentage

 

Residential

$

192,463

 

52.4

%  

$

211,939

 

56.2

%

Commercial

 

102,376

 

27.8

%  

 

95,509

 

25.3

%

Pre-Development Land

 

18,939

 

5.1

%  

 

23,466

 

6.2

%

Mixed Use

 

54,082

 

14.7

%  

 

46,077

 

12.3

%

Total

$

367,860

 

100.0

%  

$

376,991

 

100.0

%

27

Table of Contents

Allowance for Credit Losses

Our allowance for credit losses is influenced by historical loss experience, current exposure by geographical region, current expected credit losses on loans in foreclosure based on fair value less cost to sell, non-performing status, and other supportable forecasts of economic conditions. A loan is considered non-performing once it has been delinquent on its monthly payments past 90 days.

The following table presents the allowance for credit losses against unpaid principal balance of loans held for investment as of March 31, 2025 and December 31, 2024:

March 31, 2025

December 31, 2024

(in thousands)

Percentage of

Percentage of

Aggregate Gross

Respective

Aggregate Gross

Respective

Principal Amount

    

Allowance

    

Principal

    

Principal Amount

    

Allowance

    

Principal

Performing – General reserve

$

260,269

$

(4,841)

1.9

%  

$

289,910

$

(5,051)

 

1.8

%

Non-performing – General reserve

21,763

(221)

1.0

%

5,396

(96)

1.8

%

Non-performing – Direct reserves

 

61,951

 

(6,954)

11.2

%  

 

57,808

 

(7,265)

 

12.6

%

Non-performing in Foreclosure – Direct reserves

 

23,877

 

(6,106)

25.6

%  

 

23,877

 

(6,058)

 

16.7

%

Total

$

367,860

$

(18,122)

$

376,991

$

(18,470)

 

  

 

For further information, see Note 4 – Loans and Allowance for Credit Losses.

Real Estate Owned

As of March 31, 2025, we owned twenty properties, each of which previously served as collateral for first mortgage loans. One property was acquired during the three months ended March 31, 2025 in connection with foreclosure actions.

28

Table of Contents

The following table details the carrying value of each of our real estate owned properties reflected on our condensed consolidated balance sheets as of March 31, 2025:

    

    

Month of

    

Carrying

Property Type

Location

Acquisition

Value

 

(in thousands)

Commercial – Restaurant

 

Bristol, CT

 

March 2019

$

750

Land

 

Bristol, CT

 

December 2019

 

1,406

Land

 

Sturbridge, MA

 

November 2022

 

110

Residential – Single Family

 

Bellingham, MA

 

December 2023

 

293

Land

 

Stamford, CT

 

May 2024

 

115

Land

 

Stamford, CT

 

May 2024

 

115

Residential – Multi Family

 

Westbrook, ME

 

September 2024

 

298

Residential – Multi Family

 

South Portland, ME

 

September 2024

 

550

Mixed Use

 

Casco, ME

 

September 2024

 

300

Land

 

Cape Coral, FL

 

October 2024

 

600

Land

 

Cape Coral, FL

 

October 2024

 

900

Land

 

Cape Coral, FL

 

October 2024

 

350

Land

 

Cape Coral, FL

 

October 2024

 

350

Residential – Multi Family

 

Flagler Beach, FL

 

October 2024

 

3,382

Residential – Single Family

 

Gainesville, FL

 

November 2024

 

836

Mixed Use

 

New London, CT

 

November 2024

 

1,750

Land

 

New London, CT

 

November 2024

 

2,500

Commercial – Office

 

Windsor, CT

 

December 2024

 

1,600

Commercial – Office

 

Windsor, CT

 

December 2024

 

2,250

Land

 

Marathon, FL

 

January 2025

 

410

Total

 

  

$

18,865

For further information, see Note 6 – Real Estate Owned (REO).

Results of Operations

Three months ended March 31, 2025 compared to three months ended March 31, 2024

Total revenue

Total revenue for the three months ended March 31, 2025 was $11.4 million compared to $16.8 million for the three months ended March 31, 2024, a decrease of $5.4 million, or 31.9%. The change in revenue was primarily due to the cumulative effect of fewer originations over the last fifteen months resulting in a reduction in the unpaid principal balance of loans held for investment in addition to a currently elevated amount of nonperforming loans and real estate owned. On the other hand, income from our preferred membership limited liability company investments increased approximately 71.7%, quarter-over-quarter.

Operating costs and expenses

Total operating expenses for three months ended March 31, 2025 were $10.4 million compared to $12.5 million for the three months ended March 31, 2024,a decrease of $2.1 million or 16.9%. The largest contributors to this decrease were the decreases in interest and amortization of deferred financing fees as a result of the repayment of $58.2 million of aggregate principal amount of our unsecured, unsubordinated notes in 2024, and a aggregate decrease in compensation and employee benefits, provision for credit losses related to loans held for investment, and other expenses totaling $0.9 million, partially offset by $0.01 million increase in general and administrative expenses.

Other income (loss)

For the three month period ended March 31, 2025, we reported a $0.1 million loss on equity securities. For the three month period ended March 31, 2024, we reported a $0.4 million gain on equity securities.

29

Table of Contents

Net (loss) income attributable to common shareholders and net (loss) income attributable to common shareholders per share

Net loss attributable to common shareholders for the three months ended March 31, 2025 was $0.2 million, or $0.00 per share, compared to net income attributable to common shareholders of $3.6 million, or $0.08 per share, for the three months ended March 31, 2024.

Comprehensive (loss) income

For the three months ended March 31, 2025, we had no transactions which impact comprehensive income. For the three months ended March 31, 2024, we reported a reclassification of unrealized losses to provision for credit losses of $0.2 million reflecting the recognition of unrealized losses on securities held for over one year, which were not considered temporary losses, as well as an unrealized losses on investment securities of $0.3 million.

Book value per common share

The following table sets forth the calculation of our book value per common share (in thousands, except share and per share data):

    

March 31, 2025

    

December 31, 2024

Total shareholders’ equity

$

179,339

$

181,651

Series A Preferred Stock ($25 aggregate liquidation preference)

 

(57,669)

 

(57,669)

Total shareholders’ equity, net of preferred stock

$

121,670

$

123,982

Number of Common Shares outstanding at period end

 

47,310,139

 

46,965,306

Book value per common share

$

2.57

$

2.64

Book value per common share as of March 31, 2025, was $2.57, a decrease of $0.07 from our book value per common share as of December 31, 2024 of $2.64. Such decrease is primarily due to cash dividends declared and paid for the three months ended March 31, 2025 on Common Shares and Series A Preferred Stock totaling $3.5 million, or $0.07 per share.

Liquidity and Capital Resources

Total assets at March 31, 2025 were $491.4 million compared to $492.0 million at December 31, 2024, a decrease of $0.6 million, or 0.1%. The decrease was due primarily to a $9.4 million decrease in loans held for investment, net, partially offset by a $6.3 million increase in cash and $2.4 million increase in investments in real estate, net.

Total liabilities at March 31, 2025 were $312.1 million compared to $310.3 million at December 31, 2024, an increase of $1.8 million, or 0.6%. This increase is primarily due to a $7.8 million increase in our repurchase agreements, partially offset by a $3.9 million decrease in lines of credit, a $1.7 million decrease in accounts payable and accrued liabilities, and a $1.0 decrease in advances from borrowers.

Total shareholders’ equity at March 31, 2025 was $179.3 million compared to $181.7 million at December 31, 2024, a decrease of $2.3 million, or 1.3%. This decrease was due primarily to $3.5 million in dividends paid partially offset by $0.9 million of net income for the period and $0.3 million increase in additional paid-in capital related to stock-based compensation.

Sources and Uses of Funds

Our primary sources of cash include principal and interest payments on mortgage loans and various fees associated with such loans, proceeds from the sales of real property, net proceeds from offerings of equity securities, and borrowings from our credit facilities. Our primary uses of cash include debt service payments (both principal and interest), new originations of loans held for investment, new investments in real estate, dividend distributions to our shareholders, and operating expenses.

30

Table of Contents

These sources and uses of cash are reflected in our Condensed Consolidated Statements of Cash Flows as summarized below:

    

Three Months Ended

One Year-Change

 

Amount

2025

    

2024

    

Amount

    

Percentage

 

 

(in thousands)

(in thousands)

Cash and cash equivalents, January 1

$

18,066

$

12,598

$

5,468

 

43.4

%

Net cash provided by operating activities

 

191

 

4,217

 

(4,026)

 

(95.5)

%

Net cash provided by investing activities

 

5,747

 

4,319

 

1,428

 

33.1

%

Net cash provided by (used in) financing activities

 

410

 

(2,721)

 

3,131

 

115.1

%

Cash and cash equivalents, March 31

$

24,414

$

18,413

$

6,001

 

30.3

%

For a detailed breakdown of our cash flows during the three months ended March 31, 2025 and 2024, see the statement of cash flows included in our accompanying condensed consolidated financial statements.

We project anticipated cash requirements for our operating needs as well as cash flows generated from operating activities available to meet these needs. Our short-term cash requirements primarily include funding of loans, dividend payments, interest and principal payments on our indebtedness, including repayment/refinancing of the Notes maturing in September 2025, and payments for usual and customary operating and administrative expenses, such as employee compensation and sales and marketing expenses. Based on this analysis, we believe that our current cash balances, availability on our debt facilities, and our anticipated cash flows from operations will be sufficient to fund the operations for the next 12 months.

Our long-term cash needs will include principal and interest payments on outstanding indebtedness maturing late in 2026 and early 2027, preferred stock dividends and funding of new mortgage loans. Funding for long-term cash needs will come from unused net proceeds from financing activities, operating cash flows, refinancing existing debt, and proceeds from sales of real estate owned.

On March 20, 2025, we entered into a new Credit Agreement with Needham Bank, replacing the prior Needham Credit Facility, which was fully repaid and terminated on the same date. The new facility matures on March 2, 2026, and includes an option to extend the term by one year upon satisfaction of certain conditions. Under the new agreement, SN Holdings LLC (“SN Holdings”), our wholly owned subsidiary, serves as the borrower, and Sachem Capital, the parent, serves as guarantor of all obligations. The Needham Credit Facility is secured by a first priority lien on all the assets of SN Holdings, and includes a requirement that SN Holdings maintain assets equal to at least two times the outstanding principal balance under the facility. In addition, SN Holdings is required to collaterally assign to Needham Bank a portfolio of mortgage loans with an outstanding principal balance of no less than the greater of $30 million or the full drawn balance on the facility. Sachem Capital, as guarantor, has also granted Needham a blanket lien on substantially all of its assets, with the ability to request lien releases to facilitate other financings. The Needham Credit Facility, at the subsidiary borrower level, is subject to other terms and conditions, including representations and warranties, covenants and agreements typically found in these types of financing arrangements, including a covenant that requires SN Holdings to maintain: (A) a ratio of Adjusted EBITDA (as defined in the Credit Agreement) to Debt Service (as defined in the Credit Agreement) of not less than 1.40 to 1.0, tested on a trailing-twelve-month basis at the end of each fiscal quarter; (B) a sum of cash, cash equivalents (at the consolidated guarantor level) and availability under the facility equal to or greater than $10 million; and (C) an Asset Coverage Ratio (as defined) of at least 150%. As of March 31, 2025, SN Holdings had borrowed $36.1 million under the facility. The Company was in compliance with all covenants under the new agreement as of March 31, 2025. On April 1, 2025, SN Holdings made a principal payment of $9.9 million, further reducing the outstanding indebtedness to $26.2 million.

A copy of the Credit, Security and Guaranty Agreement, dated as of March 20, 2025, among SN Holdings, Sachem and Needham, is filed as Exhibit 10.8 to this Report.

Off-Balance Sheet Arrangements

We are not a party to any off-balance sheet transactions, arrangements or other relationships with unconsolidated entities or other persons that are likely to affect liquidity or the availability of our requirements for capital resources.

31

Table of Contents

Contractual Obligations

As of March 31, 2025, our contractual obligations include unfunded amounts of any outstanding construction loans and unfunded commitments for loans and limited liability company investments.

Less than

1 – 3

3 – 5

More than

    

Total

    

1 year

    

years

    

years

    

5 years

(In thousands)

Unfunded portions of outstanding construction loans

$

46,416

$

20,903

$

25,513

$

$

Unfunded commitments

 

4,771

4,771

Total contractual obligations

$

51,187

$

25,674

$

25,513

$

$

Recent Accounting Pronouncements

See “Note 2 — Significant Accounting Policies” to the unaudited condensed consolidated financial statements for explanation of recent accounting pronouncements impacting us.

Item 3.   QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

As a smaller reporting company, we are not required to provide the information required by this Item.

Item 4.   CONTROLS AND PROCEDURES

(a)

Evaluation and Disclosure Controls and Procedures

As of March 31, 2025, the Company carried out an evaluation, under the supervision and with the participation of its Principal Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of its disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Based on this evaluation, the Company’s Principal Executive Officer and Principal Financial Officer concluded that the Company’s disclosure controls and procedures were not effective as of March 31, 2025, due to the material weakness in internal control over financial reporting previously identified in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, related to stock-based compensation.

The Company is actively engaged in implementing its remediation plan to address this material weakness, including strengthening the review and approval processes for equity awards and improving oversight controls related to the terms of its equity compensation plans. These remediation efforts were ongoing as of March 31, 2025.

(b)

Changes in Internal Control Over Financial Reporting

Other than the remediation efforts described above, there was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) or 15d-15(f) under the Exchange Act) identified in connection with the evaluation required by Rules 13a-15(d) or 15d-15(d) that occurred during the fiscal quarter ended March 31, 2025 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

32

Table of Contents

PART II. OTHER INFORMATION

Item 5. OTHER INFORMATION

On March 25, 2025, the Board adopted and approved the Amended and Restated Bylaws of the Company (the “Amended and Restated Bylaws”), effective as of such date. The Amended and Restated Bylaws, among other things, adopt advance notice procedures and information requirements for shareholder nomination of directors and shareholder submission of proposals for consideration at the Company’s annual meetings of the shareholders which require shareholders to:

submit notice of their nominations and proposals 120 to 90 days before the anniversary of the prior year’s annual meeting; and
provide information about the nominating or proposing shareholder and their nominees or proposal. Relevant provisions require:

(i)

information about persons collaborating with a noticing party;

(ii)

information about derivative instruments held by a noticing party;

(iii)

information about interests of a noticing party in the Company’s principal competitors;

(iv)

information about a noticing party and its nominees that are required in proxy statements and Schedule 13D filings; and

(v)

compliance by a noticing party with state law and federal securities law related to making nominations and proposals.

A copy of the Amended and Restated Bylaws is filed as Exhibit 3.2 to this report.

33

Table of Contents

Item 6.   EXHIBITS

Exhibit No.

    

Description

2.1

Form of Amended and Restated Exchange Agreement (1)

3.1

Certificate of Incorporation (1)

3.1(a)

Certificate of Amendment to Certificate of Incorporation (1)

3.1(b)

Certificate of Amendment to Certificate of Incorporation filed on October 7, 2019 (2)

3.1(c)

Certificate of Amendment to Certificate of Incorporation filed on June 25, 2021 (8)

3.1(d)

Certificate of Amendment to Certificate of Incorporation filed on July 19, 2022 (18)

3.1(e)

Certificate of Amendment to Certificate of Incorporation filed on August 23, 2022 (12)

3.2

Amended and Restated Bylaws, effective as of March 25, 2025 (21)

4.1

Indenture, dated as of June 21, 2019, between Sachem Capital Corp. and U.S. Bank National Association, as Trustee (3)

4.2

Third Supplemental Indenture between Sachem Capital Corp. and U.S. Bank National Association, as Trustee (4)

4.3

Form of 7.75% Notes due 2025 (included as Exhibit A to Exhibit 4.2 above)

4.4

Specimen 7.75% Series A Cumulative Redeemable Preferred Stock Certificate. (8)

4.5

Fourth Supplemental Indenture between Sachem Capital Corp. and U.S. Bank National Association, as Trustee (5)

4.6

Form of 6.00% Note due 2026 (attached as Exhibit A to Exhibit 4.5 above).

4.7

Fifth Supplemental Indenture between Sachem Capital Corp. and U.S. Bank Trust Company, National Association, as Trustee (9)

4.8

Form of 6.00% Note due 2027 (attached as Exhibit A to Exhibit 4.7 above)

4.9

Sixth Supplemental Indenture between Sachem Capital Corp. and U.S. Bank Trust Company, National Association, as Trustee (22)

4.10

Form of 7.125% Note due 2027 (attached as Exhibit A to Exhibit 4.9 above)

4.11

Seventh Supplemental Indenture between Sachem Capital Corp. and U.S. Bank Trust Company, National Association, as Trustee (11)

4.12

Form of 8.00% Note due 2027 (attached as Exhibit A to Exhibit 4.11 above)

4.13

Revolving Credit Note, dated March 20, 2025, in the principal amount of $50 million in favor of Needham Bank, as lender (20)

10.1**

Employment Agreement by and between John L. Villano and Sachem Capital Corp. (1)

10.1(a)**

Amendment to Employment Agreement by and between John L. Villano and Sachem Capital Corp. (6)

10.2

Sachem Capital Corp. 2016 Equity Compensation Plan (1)

10.3

Master Repurchase Agreement and Securities Contract, dated as of July 21, 2021, between Sachem Capital Corp. and Churchill MRA Funding I LLC (7)

10.4

Custodial Agreement, dated as of July 21, 2021, among Sachem Capital Corp., Churchill MRA Funding I LLC. and U.S. Bank National Association (7)

10.5**

Agreement and General Release, dated as of January 14, 2022, between Sachem Capital Corp. and Peter J. Cuozzo (10)

10.6**

Final Form of the Restrictive Stock Grant Agreement dated July 19, 2022 under the Sachem Capital Corp. 2016 Equity Compensation Plan between Sachem Capital Corp. and each of Leslie Bernhard, Arthur Goldberg and Brian Prinz (18)

10.7

Credit and Security Agreement, dated as of March 20, 2025, among SN Holdings, as the borrower, Sachem Capital Corp., as the gurantor, the lenders party thereto and Needham Bank, as administrative agent (20)

10.8**

Final Form of the Restrictive Stock Grant Agreement dated February 17, 2023 under the Sachem Capital Corp. 2016 Equity Compensation Plan between the Company and John L. Villano (14)

10.9**

Final Form of the Restricted Stock Grant Agreement dated March 19, 2024 under the Sachem Capital Corp. 2016 Equity Compensation Plan between the Company and John L. Villano (15)

10.10

Cooperation Agreement, dated August 20, 2024, between Sachem Capital Corp. and Blackwells Capital LLC, Blackwells Onshore I LLC and Jason Aintabi (16)

10.11**

Final Form of the Restrictive Stock Grant Agreement dated September 7, 2023 under the Sachem Capital Corp. 2016 Equity Compensation Plan between Sachem Capital Corp. and each of Leslie Bernhard, Arthur Goldberg and Brian Prinz(17)

10.12**

Letter Agreement, dated December 13, 2024, between the Company and Jeffery C. Walraven (a portion of the exhibit has been excluded from the exhibit because it both (i) is not material and (ii) is the type that the company treats as private or confidential) (19)

34

Table of Contents

10.13**

Final Form of the Restrictive Stock Grant Agreement dated March 10, 2025 under the Sachem Capital Corp. 2016 Equity Compensation Plan between Sachem Capital Corp. and each of Arthur Goldberg, Brian Prinz and Jeffery Walraven (21)

31.1

Chief Executive Officer Certification as required under section 302 of the Sarbanes Oxley Act *

31.2

Chief Financial Officer Certification as required under section 302 of the Sarbanes Oxley Act *

32.1

Chief Executive Officer Certification pursuant to 18 U.S.C. section 1350 as adopted pursuant to section 906 of the Sarbanes Oxley Act ***

32.2

Chief Financial Officer Certification pursuant to 18 U.S.C. section 1350 as adopted pursuant to section 906 of the Sarbanes Oxley Act ***

97.1

Policy Relating to Recovery of Erroneously Awarded Compensation (15)

99.1

Open-End Construction Mortgage, Security Agreement and Assignment of Leases and Rents, dated February 28, 2023, by Sachem Capital Corp., in connection with the New Haven Bank Mortgage refinancing (13)

99.2

Commercial Term Note made by Sachem Capital Corp to New Haven Bank, dated February 28, 2023, in the principal amount of $1,660,000 (attached as Exhibit B to Exhibit 99.1 above)

99.3

Loan Agreement between Sachem Capital Corp. and New Haven Bank, dated as of February 28, 2023 (13)

99.4

Mortgage Release releasing Sachem Capital Corp. from the $1.4 million NHB Mortgage (13)

101.INS

XBRL Instance Document *

101.SCH

XBRL Taxonomy Extension Schema Document *

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document *

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document *

101.LAB

XBRL Taxonomy Extension Label Linkbase Document *

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document *

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)*

*

Filed herewith.

**

Compensation plan or arrangement for current or former executive officers and directors.

***

Furnished, not filed, in accordance with item 601(32)(ii) of Regulation S-K.

(1)Previously filed as an exhibit to the Registration Statement on Form S-11, as amended (SEC File No.: 333-214323) and incorporated herein by reference.
(2)Previously filed as an exhibit to the Quarterly Report on Form 10-Q for the period ended September 30, 2019 and incorporated herein by reference.
(3)Previously filed as an exhibit to the Current Report on Form 8-K on June 25, 2019 and incorporated herein by reference.
(4)Previously filed as an exhibit to the Current Report on Form 8-K on September 9, 2020 and incorporated herein by reference.
(5)Previously filed as an exhibit to the Current Report on Form 8-K on December 20, 2021 and incorporated herein by reference.
(6)Previously filed as an exhibit to the Current Report on Form 8-K on April 14, 2021 and incorporated herein by reference.
(7)Previously filed as an exhibit to the Current Report on Form 8-K on July 27, 2021 and incorporated herein by reference.
(8)Previously filed as an exhibit to the Current Report on Form 8-K on June 29, 2021 and incorporated herein by reference.
(9)Previously filed as an exhibit to the Current Report on Form 8-K on March 9, 2022 and incorporated herein by reference.
(10)Previously filed as an exhibit to the Annual Report on Form 10-K for the year ended December 31, 2021 and incorporated herein by reference.

35

Table of Contents

(11)Previously filed as an exhibit to the Current Report on Form 8-K on August 23, 2022 and incorporated herein by reference.
(12)Previously filed as an exhibit to the Current Report on Form 8-K on August 24, 2022 and incorporated herein by reference.
(13)Previously filed as an exhibit to the Current Report on Form 8-K on March 3, 2023 and incorporated herein by reference.
(14)Previously filed as an exhibit to the Quarterly Report on Form 10-Q for the period ended March 31, 2023 and incorporated herein by reference.
(15)Previously filed as an exhibit to the Annual Report on Form 10-K for the year ended December 31, 2023 and incorporated herein by reference.
(16)Previously filed as an exhibit to the Current Report on Form 8-K on August 26, 2024 and incorporated herein by reference.
(17)Previously filed as an exhibit to the Quarterly Report on Form 10-Q for the period ended September 30, 2024 and incorporated herein by reference.
(18)Previously filed as an exhibit to the Quarterly Report on Form 10-Q for the period ended June 30, 2022 and incorporated herein by reference.
(19)Previously filed as an exhibit to the Current Report on Form 8-K on December 16, 2024 and incorporated herein by reference.
(20)Previously filed as an exhibit to the Current Report on Form 8-K on March 27, 2025 and incorporated herein by reference.
(21)Previously filed as an exhibit to the Annual Report on Form 10-K for the year ended December 31, 2024 and incorporated herein by reference.
(22)Previously filed as an exhibit to the Current Report on Form 8-K on May 12, 2022 and incorporated herein by reference.

36

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.

SACHEM CAPITAL CORP.

Date: May 1, 2025

By:

/s/ John L. Villano

 

 

John L. Villano, CPA

President and Chief Executive Officer

(Principal Executive Officer)

Date: May 1, 2025

By:

/s/ Jeffery C. Walraven

 

 

Jeffery C. Walraven

Interim Chief Financial Officer

(Principal Accounting and Financial Officer)

37